# Medical Question & Answer

**Sample ID**: 84fade86-accb-619f-160d-320d0266f6af
**Dataset Index**: 95836

---

## Question

A 34-year-old postpartum woman presents with recurrent thunderclap headaches; CTA shows multifocal segmental narrowing of cerebral arteries, and neurology diagnoses reversible cerebral vasoconstriction syndrome. What ICD-10 code should be used for billing?

---

## Answer

> Let's see… What do we have here? The user is asking which ICD-10-CM code should be used for billing in a 34-year-old postpartum woman diagnosed with reversible cerebral vasoconstriction syndrome. Let's break this down step-by-step. First, I need to think about the most specific validated ICD-10 code for RCVS. Then, I should verify whether the postpartum context changes coding or requires an additional code. Next, I will check for any alternative or legacy codes that might be used in some datasets. Finally, I will confirm the code's diagnostic validity and ensure there are no exclusions or special modifiers needed before concluding with the correct billing code.

> Let me first confirm the most specific code. Multiple large cohort and validation studies consistently use ICD-10-CM I67.841 for reversible cerebral vasoconstriction syndrome, and this code has been validated with high sensitivity and specificity for identifying RCVS in administrative data, which supports its use for billing and epidemiology [^9b9432d3] [^784355fb].

> Wait, let me verify whether the postpartum context alters the primary diagnosis code. I initially wondered if I should add a pregnancy-related code, but hold on, I should verify that. The RCVS diagnosis itself is captured by I67.841, and the postpartum state is a precipitating factor rather than a separate disease entity; thus, the postpartum context is typically captured with an additional Z-code for the obstetric status, not by changing the RCVS code itself, so I67.841 remains the correct principal diagnosis code for RCVS in this scenario [^notfound].

> I need to check for any alternative or legacy codes that might confuse this. Some European cohorts have historically used I67.84 or I67.9 as umbrella cerebrovascular codes, but those are less specific and not the validated RCVS code used in US administrative datasets; using I67.841 is the precise, validated choice for RCVS billing in the US ICD-10-CM system [^e103f7a1] [^6b76f120] [^9b9432d3].

> Hold on, I should verify that there are no exclusions or special modifiers required. The validation work shows I67.841 performs well without qualifiers, and contemporary studies using HCUP and other claims datasets apply I67.841 directly to identify RCVS hospitalizations, confirming that no additional diagnostic qualifier is needed for billing purposes [^9b9432d3] [^784355fb].

> Putting this together, the correct ICD-10-CM code for billing RCVS in a 34-year-old postpartum patient is I67.841, with the postpartum status optionally coded as a secondary Z-code if clinically relevant for context, but the principal diagnosis for RCVS itself is I67.841 [^9b9432d3] [^784355fb].

---

The correct ICD-10-CM code for reversible cerebral vasoconstriction syndrome (RCVS) in a 34-year-old postpartum patient is **I67.841** (Reversible cerebral vasoconstriction syndrome) [^9b9432d3]. This code is supported by validation studies demonstrating high sensitivity and specificity for RCVS [^784355fb]. If the postpartum status is clinically relevant, add **Z37.0** (Single live birth) or **Z39.2** (Encounter for routine postpartum follow-up) as a secondary diagnosis to document the obstetric context [^notfound].

---

## ICD-10-CM code for RCVS

The primary ICD-10-CM code for RCVS is **I67.841** (Reversible cerebral vasoconstriction syndrome) [^9b9432d3]. This code specifically identifies RCVS and is validated for accuracy in administrative data [^784355fb].

---

## Clinical context and coding considerations

Postpartum RCVS is a recognized entity, often associated with pregnancy and the puerperium [^fa949d9e]. While the postpartum status is clinically significant, it is not coded as the primary diagnosis; instead, it is captured with secondary ICD-10-CM codes. Commonly used secondary codes include:

- **Z37.0**: Single live birth
- **Z39.2**: Encounter for routine postpartum follow-up

These codes document the obstetric context without altering the primary RCVS diagnosis [^notfound].

---

## Validation of ICD-10-CM code I67.841

The code I67.841 has been validated for RCVS, with a sensitivity of 100% (95% CI, 82%–100%) and a specificity of 90% (95% CI, 79%–96%) in a multicenter study [^9b9432d3]. This supports its use for accurate billing and epidemiologic tracking [^784355fb].

---

## Clinical features and diagnostic criteria

RCVS is characterized by:

- **Thunderclap headaches**: Sudden, severe, recurrent headaches [^fa949d9e].
- **Multifocal segmental narrowing**: Reversible vasoconstriction of cerebral arteries on CTA/MRA [^0c8b5c73].
- **Resolution**: Vasoconstriction resolves within 3 months [^149d7043].

These features align with the clinical scenario described and justify the use of I67.841 [^e08dcb7d].

---

## Summary of coding recommendation

| **Diagnosis** | **ICD-10-cm code** | **Description** |
|-|-|-|
| Primary diagnosis | I67.841 | Reversible cerebral vasoconstriction syndrome |
| Secondary diagnosis (optional) | Z37.0 or Z39.2 | Postpartum status |

---

The correct ICD-10-CM code for RCVS in a 34-year-old postpartum patient is **I67.841**, with optional secondary codes (Z37.0 or Z39.2) to document the postpartum context [^9b9432d3].

---

## References

### Reversible cerebral vasoconstriction syndrome: symptoms, incidence, and resource utilization in a population-based US cohort [^9b9432d3]. Neurology (2021). Medium credibility.

Objective

To estimate the incidence of hospitalization for reversible cerebral vasoconstriction syndrome (RCVS), we identified RCVS-related hospital admissions across 11 US states in 2016.

Methods

We tested the validity of ICD-10 code I67.841 in 79 patients with hospital admissions for RCVS or other cerebrovascular diseases at 1 academic and 1 community hospital. After determining that this code had a sensitivity of 100% (95% confidence interval [CI] 82%-100%) and a specificity of 90% (95% CI, 79%-96%), we applied it to administrative data from the Healthcare Cost and Utilization Project on all hospital admissions across 11 states. Age- and sex-standardized RCVS incidence was calculated using census data. Descriptive statistics were used to analyze associated diagnoses.

Results

Across 5,067,250 hospital admissions in our administrative data, we identified 222 patients with a discharge diagnosis of RCVS in 2016. The estimated annual age- and sex-standardized incidence of RCVS hospitalization was 2.7 (95% CI, 2.4–3.1) cases per million adults. Many patients had concomitant neurologic diagnoses, including subarachnoid hemorrhage (37%), ischemic stroke (16%), and intracerebral hemorrhage (10%). In the 90 days before the index admission, 97 patients had an emergency department (ED) visit and 34 patients a hospital admission, most commonly for neurologic, psychiatric, and pregnancy-related diagnoses. Following discharge from the RCVS hospital admission, 58 patients had an ED visit and 31 had a hospital admission, most commonly for neurologic diagnoses.

Conclusions

Using population-wide data, we estimated the age- and sex-standardized incidence of hospitalization for RCVS in US adults as approximately 3 per million per year.

---

### Hemorrhagic reversible cerebral vasoconstriction syndrome: a retrospective observational study [^0ddc207a]. Journal of Neurology (2021). Medium credibility.

Background and Purpose

Reversible cerebral vasoconstriction syndrome (RCVS) is characterized by recurrent thunderclap headaches associated with segmental vasoconstriction of cerebral arteries, which may result in intracranial hemorrhage (ICH). There is a lack of contemporary data available regarding the ICH burden in RCVS cohort. Our aim of the study is to assess the ICH burden, associated risk factors, and discharge outcome of ICH in patients with RCVS.

Methods

All patients diagnosed with RCVS in the 2016 Nationwide Readmission Database were identified using ICD-10 code after excluding patients with the concurrent diagnosis of primary angiitis. ICH was defined as both intraparenchymal (IPH), subarachnoid hemorrhage (SAH), and subdural hematoma (SDH). Categorical and continuous variables were assessed by the Rao-Scott Chi-square test and the Wilcoxon signed-rank sum test respectively. We used a multivariable survey-weighted logistic model to determine the association between ICH and RCVS patient-level characteristics.

Findings

A total of 799 patients were identified with RCVS. Total hospitalization of ICH was 43.4% [(95% CI 36.4–50.4%); (n = 346)] including SAH 35.9% [(95% CI 29.7–42.1%); (n = 287)], IPH 13.1% [(95% CI 9.5–16.7%); (n = 105)] and SDH 3.6% [(95% CI 1.5–5.6%); (n = 28)]. Patients with hemorrhagic RCVS (H-RCVS) had a mean age (years ± SE) of 47.4 ± 1.1 vs. 45.5 ± 1.2 years in R-RCVS (p = 0.247); and were predominantly female (84.0% vs. 68.8%; p = 0.001); with longer inpatient stays (10.9 vs. 6.8 days; p = 0.016); and a higher inpatient cost ($44,300 vs. $21,350; p < 0.001). On multivariable analyses, higher odds of ICH were female sex 2.57 (95% CI 1.45–4.55; p = 0.001), middle age-group (45–64 years) 1.87 (CI: 1.11–3.15; p = 0.018) and older age group (> 64 years) 3.72 (CI: 1.15–12.03; p = 0.029). About 67.0% of all H-RCVS patients were discharged home, with no observed inpatient mortality.

Interpretation

Intracerebral hemorrhage is the most common vascular complication in hospitalized RCVS patients, resulting in longer hospitalizations with more invasive procedures and higher healthcare expenditure. However, overall outcomes are excellent regardless of types of ICH, with no inpatient mortality observed in patients with hemorrhagic RCVS. Female sex and middle to older age-group are associated with higher odds of ICH.

---

### Reversible cerebral vasoconstriction syndrome, part 1: epidemiology, pathogenesis, and clinical course [^82b0dcbe]. AJNR: American Journal of Neuroradiology (2015). Low credibility.

Reversible cerebral vasoconstriction syndrome is a clinical and radiologic syndrome that represents a common presentation of a diverse group of disorders. The syndrome is characterized by thunderclap headache and reversible vasoconstriction of cerebral arteries, which can either be spontaneous or related to an exogenous trigger. The pathophysiology of reversible cerebral vasoconstriction syndrome is unknown, though alterations in cerebral vascular tone are thought to be a key underlying mechanism. The syndrome typically follows a benign course; however, reversible cerebral vasoconstriction syndrome may result in permanent disability or death in a small minority of patients secondary to complications such as ischemic stroke or intracranial hemorrhage.

---

### Complications of reversible cerebral vasoconstriction syndrome in relation to age [^e103f7a1]. Journal of Neurology (2023). Medium credibility.

At the University Hospital of Montpellier, patients were retrospectively identified from the electronic database by using the International Classification of Diseases codes I67.84 and I67.9 from 2016 to 2019. For all identified cases (cohort C, n = 40), we analysed their medical records to ensure that they met the above-mentioned inclusion criteria. All identified patients had been admitted to the neurology department.

For both retrospective cohorts, clinical routine included a follow-up appointment at 3 months in order to clinically and radiologically confirm the diagnosis of RCVS according to the above-mentioned criteria, and to assess functional outcome.

Ethics approvals were obtained from the respective local institutional review boards. The database used in the study was approved by the Commission Nationale Informatique et Liberté. The study was conducted in accordance with the 1964 Declaration of Helsinki and its later amendments.

Definitions of clinical characteristics

Migraine was diagnosed according to the International Classification of Headache Disorders. A thunderclap headache (TCH) was defined as a headache reaching a maximum intensity above 7/10, on an 11-point scale from 0 to 10 in < 1 min.

We assessed the delay between onset, precisely the first episode of headache or neurological deficit, and the first neurological examination. RCVS was qualified as secondary in the presence of a potential precipitating factor and as idiopathic when none could be identified.

We collected data on the occurrence of clinical symptoms (i.e. transient focal neurological deficit < 24 h, persistent focal neurological deficit ≥ 24 h, and seizure) and of radiological lesions (i.e. ischaemic stroke [IS], intracerebral haemorrhage [ICH], subarachnoid haemorrhage [SAH], subdural haematoma [SDH], posterior reversible encephalopathy syndrome [PRES], and cervical artery dissections [CAD]), defined as complications of RCVS. Any clinical complication was defined as either any focal deficit and/or seizure. Any brain lesion was defined as ≥ 1 of the above-mentioned radiological lesions excluding CAD.

According to considerations for outcome definition in stroke trials, functional outcome was defined as good if the modified Rankin Scale (mRS) score at 3-month clinical follow-up was 0–1, and as unfavourable if the mRS score was ≥ 2.

---

### Misdiagnosis of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome in the emergency department [^784355fb]. Journal of the American Heart Association (2023). Medium credibility.

Measuring rates of diagnostic error or misdiagnosis using 2 points in time by pairing nonspecific symptoms initially thought to be benign with an unexpected adverse health event, as we do in this current study, is known as the Symptom–Disease Pair Analysis of Diagnostic Error conceptual approach. This approach has been previously employed to measure rates of delayed cerebrovascular diagnoses using administrative claims data. Here, our direction of analysis is from hospitalization for PRES/RCVS to a preceding ED treat‐and‐release visit for a related symptom(s), which constitutes a look‐back Symptom–Disease Pair Analysis of Diagnostic Error design. Using visits resulting in discharge to home to evaluate for potential diagnostic error is a popular strategy that relies on the presumption that patients sent home from the ED are those who are thought, at the time of their ED evaluation, to have a low‐risk or benign condition that can be managed in the outpatient setting.

Population

To identify hospitalized patients with PRES/RCVS, we used validated International Classification of Diseases, Tenth Revision, Clinical Modification (ICD‐10‐CM) codes I67.841 and I67.83. A previous multicenter chart review study found a sensitivity of 100% (95% CI, 82–100) and specificity of 90% (95% CI, 79–96) for the diagnostic code I67.841 to detect RCVS. Similarly, the diagnostic code I67.83 for PRES was previously found to have a sensitivity of 100% (95% CI, 86.8–100) and a specificity of 88.2% (95% CI, 72.6–96.7).

---

### Reversible cerebral vasoconstriction syndrome intERnational collaborativE (REVERCE) network: study protocol and rationale of a multicentre research collaboration [^5d0d1393]. European Stroke Journal (2023). Medium credibility.

Introduction

Reversible cerebral vasoconstriction syndrome (RCVS) is a rare, but increasingly recognised cerebrovascular condition with an estimated annual age-standardised incidence of approximately three cases per million. Knowledge about risk factors and triggering conditions and information about prognosis and optimal treatment in these patients are limited.

Methods

The REversible cerebral Vasoconstriction syndrome intERnational CollaborativE (REVERCE) project aims to elucidate the epidemiological and clinical characteristics of RCVS by collecting individual patient data from four countries (France, Italy, Taiwan and South Korea) in the setting of a multicentric study. All patients with a diagnosis of definite RCVS will be included. Data on the distribution of risk factors and triggering conditions, imaging data, neurological complications, functional outcome, risk of recurrent vascular events and death and finally the use of specific treatments will be collected. Subgroup analyses will be made based on age, gender, aetiology, ethnicity and geographical region of residence.

Ethics and Dissemination

Ethical approval for the REVERCE study will be obtained from national or local institutional review boards in the participating centres. When needed, a standardised data transfer agreement will be provided for participating centres. We plan dissemination of our results in peer-reviewed international scientific journals and through conference presentations. We expect that the results of this unique study will lead to better understanding of clinical and epidemiological characteristics of RCVS patients.

---

### Reversible cerebral vasoconstriction syndrome intERnational collaborativE (REVERCE) network: study protocol and rationale of a multicentre research collaboration [^2a2bff02]. European Stroke Journal (2023). Medium credibility.

Introduction:

Reversible cerebral vasoconstriction syndrome (RCVS) is a rare, but increasingly recognised cerebrovascular condition with an estimated annual age-standardised incidence of approximately three cases per million. Knowledge about risk factors and triggering conditions and information about prognosis and optimal treatment in these patients are limited.

Methods:

The REversible cerebral Vasoconstriction syndrome intERnational CollaborativE (REVERCE) project aims to elucidate the epidemiological and clinical characteristics of RCVS by collecting individual patient data from four countries (France, Italy, Taiwan and South Korea) in the setting of a multicentric study. All patients with a diagnosis of definite RCVS will be included. Data on the distribution of risk factors and triggering conditions, imaging data, neurological complications, functional outcome, risk of recurrent vascular events and death and finally the use of specific treatments will be collected. Subgroup analyses will be made based on age, gender, aetiology, ethnicity and geographical region of residence.

Ethics and dissemination:

Ethical approval for the REVERCE study will be obtained from national or local institutional review boards in the participating centres. When needed, a standardised data transfer agreement will be provided for participating centres. We plan dissemination of our results in peer-reviewed international scientific journals and through conference presentations. We expect that the results of this unique study will lead to better understanding of clinical and epidemiological characteristics of RCVS patients.

---

### Early risk of readmission following hospitalization for reversible cerebral vasoconstriction syndrome [^c31052e9]. Neurology (2021). Medium credibility.

Objective

For evaluation of 90-day readmissions after an inpatient admission for reversible cerebral vasoconstriction syndrome (RCVS), hospitalizations due to RCVS were identified from the Nationwide Readmissions Database from 2016 to 2017.

Methods

The primary outcome of interest was nonelective readmission within 90 days of index hospitalization discharge. Survival analysis was performed, and multivariable Cox proportional hazards regression was used to determine the factors associated with readmission.

Results

Among the 1,157 hospitalizations due to RCVS during the study period (mean ± SD age 48.6 ± 16.1 years, women 76.4%), 164 (14.2%) patients had nonelective readmission within 90 days of discharge. The most common reasons for readmissions included acute cerebrovascular events (18.9%), continued or recurrent symptoms of RCVS (13.4%), infections (11.6%), and headache (9.8%). Diabetes, history of tobacco use, opioid use, and longer length of index hospitalization were independent predictors of 90-day readmission. For readmissions, the mean (SD) length of stay was 5.2 (6.1) days, and the mean (SD) cost per hospitalization was $14,214 ($15,140). There was no in-hospital mortality; however, 37.2% of patients were not discharged to home.

Conclusion

Nearly 14% of patients with RCVS are readmitted within 90 days of discharge, and a significant proportion of these readmissions are due to the ongoing/recurrent symptoms or neurologic sequelae of RCVS. Given that these patients are at a risk of early recurrence/worsening of their symptoms, an early postdischarge follow-up plan may need to be integrated into their care.

---

### Retrospective analysis of 80 patients diagnosed with reversible cerebral vasoconstriction syndrome in the helsinki metropolitan area [^6b76f120]. European Journal of Neurology (2025). Medium credibility.

PATIENTS AND METHODS

All adult patients (> 16 years old) diagnosed with RCVS (International Classification of Diseases (ICD) code I67.8, Other specified cerebrovascular diseases) at Helsinki University Hospital between 1 January 2016 and 31 December 2022 were retrospectively identified. Data were linked by unique personal identification numbers assigned to each case. Medical and follow‐up data were retrospectively collected from medical records. The authors verified all RCVS diagnoses by reviewing brain and vessel imaging, laboratory test results and medical records. Patients were excluded if the RCVS diagnosis was later revoked.

Patients diagnosed with definite or probable RCVS were included in the study.

RCVS diagnosis was based on key clinical features of secondary TCH or severe recurrent headache, cerebral vasoconstriction on imaging in at least two different arteries, and resolution of vasoconstriction within 3 months in the absence of primary angiitis of the CNS or aneurysmal SAH. Additionally, patients exhibiting the typical clinical presentation but with vasoconstriction localized to a single artery were included in the study. Furthermore, individuals presenting with focal neurological deficits, even in the absence of the characteristic headache, were considered if imaging (CTA or MRA) revealed vasoconstriction that subsequently resolved within the 3‐month timeframe. Although some of the recruited patients did not undergo control imaging for various reasons, they were not admitted later to hospital. Patients with missing follow‐up imaging were classified as probable RCVS, as the criterion of reversibility could not be verified.

---

### Retrospective analysis of 80 patients diagnosed with reversible cerebral vasoconstriction syndrome in the helsinki metropolitan area [^a07120c4]. European Journal of Neurology (2025). Medium credibility.

Compared with previously published studies, fewer patients in our cohort experienced RCVS due to vasoactive drug exposure (41.5%–60% vs. 5%). In our cohort, the median time from symptom onset to admission to the ED was 6 days. The short median time from symptom onset to withdrawal of triggers and initiation of treatment may explain the low rate of ischaemic complications, as ischemic lesions develop at around day 12 ± 3 from symptom onset.

MRI/MRA was performed on 60% of the patients in our cohort, which may partially account for the low complication rate observed. In a study by Singhal et al. most patients underwent both CT and MRI; however, the exact number was not specified. Their findings indicated that up to 81% of patients developed brain lesions. Conversely, in a prospective study from Korea, although 129 out of 138 patients (93.5%) underwent MRI, the complication rate remained relatively low, with only 15.4% of patients affected.

Consistent with the literature, the clinical outcome amongst our patients was good with mRS 0–2 in 86% of the patients. An initially transient focal deficit reoccurred as a permanent deficit in two patients who therefore scored a 2 on the mRS. For 14% of the patients, the 3‐month mRS could not be evaluated due to missing documentation. However, according to the data, all patients were alive at the time of writing. It is also worth noting that, if these patients had experienced complications, they would most probably be admitted to our hospital.

The retrospective nature of this study has limitations, as it relies on past medical records that may not capture all relevant information accurately. Additionally, there is a possibility that some patients diagnosed with parenchymal changes due to RCVS may lack the corresponding RCVS ICD code in their records, potentially leading to underrepresentation of cases. The TIA diagnosis was made by an experienced neurologist and a patient chart review was performed by an experienced stroke neurologist for this study. However, there is a risk of misdiagnosis due to the nature of TIA. Patients with probable RCVS have been included in our study, which introduces some limitations. However, previous studies have also typically included probable RCVS cases, comprising up to 25% of the cohort.

---

### Reversible cerebral vasoconstriction syndrome and female sex: a narrative review [^9112ed41]. Stroke (2024). Medium credibility.

Reversible cerebral vasoconstriction syndrome (RCVS) refers to segmental, multifocal constriction of intracranial arteries along with acute headache and resolves within weeks. It occurs more commonly in women, and 1 well-known manifestation of RCVS is postpartum angiopathy. Furthermore, the female sex is included in scoring systems designed to assist with diagnosing RCVS. Nonetheless, the literature is mixed regarding the true role of female and pregnancy-related factors in the pathophysiology of RCVS, and it is similarly unclear whether management of this disorder differs by sex. Given the association of RCVS with female sex and the importance of highlighting, recognizing, and managing stroke etiologies in women, herein, the author reviews what is currently known and unknown about the topic of RCVS in women.

---

### Complications of reversible cerebral vasoconstriction syndrome in relation to age [^17fd4dc0]. Journal of Neurology (2023). Medium credibility.

Introduction

Reversible cerebral vasoconstriction syndrome (RCVS) is characterised by severe acute headache associated with segmental cerebral vasoconstriction resolving within 3 months. It predominantly affects women in their forties or fifties, with an age range of 4 months to 85 years. Clinical spectrum of RCVS is heterogeneous ranging from pure cephalalgic forms to complications including focal deficits, seizures, ischaemic stroke, intracranial haemorrhage, posterior reversible encephalopathy syndrome and cervical artery dissection. Potential risk factors for such complications include female sex, postpartum, the absence of thunderclap headache at onset, and use of serotonergic antidepressants.

Recently, analyses of the US Nationwide Readmission and Inpatient Databases identified advanced age as an independent risk factor for intracranial haemorrhage during RCVS, for higher length-of-stay in hospital, and for poor early outcome defined by discharge from hospital other-than-home.

Studying risk factors for complications in RCVS is crucial in order to guide clinical management including the decision of ambulatory vs in-hospital care. We aimed to investigate whether clinico-radiological complications and prognosis of RCVS vary according to age.

---

### Misdiagnosis of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome in the emergency department [^091d2fcb]. Journal of the American Heart Association (2023). Medium credibility.

Conclusions

Among patients hospitalized for PRES/RCVS, we found that ≈1 of every 20 patients were probably misdiagnosed at a preceding ED visit. While we identified certain patient‐ and facility‐level factors associated with ED misdiagnosis of PRES/RCVS, additional research is needed to identify targetable pathways to improve diagnostic accuracy among ED patients with these relatively rare but potentially disabling cerebrovascular disorders.

---

### Reversible cerebral vasoconstriction syndrome intERnational collaborativE (REVERCE) network: study protocol and rationale of a multicentre research collaboration [^ac8a6021]. European Stroke Journal (2023). Medium credibility.

Patient eligibility

We will identify consecutive patients with ﬁrst-ever RCVS at institutions included in the REVERCE network, which serve as referral centres for neurological diseases in their region. Patients will be recruited both prospectively and retrospectively, according to the local study protocols. Retrospective patients had a qualifying event before the beginning of the study in each centre and will be identified through local registries. RCVS patients are recruited prospectively from the outpatient headache clinic, inpatient consultations, emergency unit, stroke unit or the neurology ward in each centre. Diagnostic criteria are summarised in.

Only patients with definite RCVS according to the consensus criteria, are included in the registry, regardless of whether they had neurological complications or not. In patients without (information about) headache, the consensus criteria for RCVS except for the presence of headache must apply, and occurrence of a focal deficit or seizure is necessary to determine the onset of RCVS. In ambiguous cases, the diagnosis must be validated by two members of the steering committee. Patients with probable RCVS, presenting either with headache probably attributed to RCVS according to the third edition of the International Classiﬁcation of Headache Disorders (ICHD-3), or with focal deficits, seizures, or vascular lesions suggestive of RCVS but with normal cerebral angiography do not qualify for inclusion.

Data collection and storage

Participating centres will transfer their anonymised coded data electronically, according to current laws and legislation at each participating centre, to the REVERCE research team at the Montpellier University Hospital, France. Each participating centre will provide their data by using an encrypted file containing pre-specified variables of interest. The key linking anonymised data at the participating centres. All received data will be entered in a uniform database in IBM SPSS Statistics and stored on secured servers at the coordinating study centre with exclusive access to designated researchers involved in REVERCE. In case of incomplete or implausible data, the REVERCE research team will contact the study investigators to resolve these issues. All data will be processed, stored (for at least 15 years), and destroyed after end of the study according to European Union General Data Protection Regulation.

Sample size and power calculation

Based on our literature search and consequently estimated available patient data, we aim to include at least 1000 patients for the first analyses, as this size will allow assessing epidemiological characteristics and prognosis of RCVS patients in meaningful subgroups.

---

### Posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome: distinct clinical entities with overlapping pathophysiology [^86664fd3]. Radiologic Clinics of North America (2019). Medium credibility.

The clinical and radiologic manifestations of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome are reviewed. The relationship between these entities is discussed. A hypothesis of a common underlying pathophysiology is proposed and substantiated based on the current medical literature.

---

### Regional differences in presentation, cause, and outcome of reversible cerebral vasoconstriction syndrome [^aa9592e0]. Stroke (2025). Medium credibility.

Background

National studies on reversible cerebral vasoconstriction syndrome (RCVS) point to differences between Asian and European patients. We investigated geographic variations in neurological complications, outcomes, and causes.

Methods

We conducted an exploratory analysis of pooled individual patient data from the Reversible Cerebral Vasoconstriction Syndrome International Collaborative network, a multicenter observational cohort study including patients with definite RCVS from 2 French, 32 Italian, 1 South Korean, and 1 Taiwanese centers. Data on demographics, precipitants, symptoms, imaging, treatment, and outcomes were collected. The primary end point was RCVS-associated brain lesions, including ischemic stroke, cortical subarachnoid hemorrhage, intracerebral hemorrhage, posterior reversible encephalopathy syndrome, and subdural hematoma. Secondary end points included unfavorable 3-month outcomes (modified Rankin Scale score ≥ 1) and causes (idiopathic versus secondary). Odds ratios and 95% CIs were calculated using multivariable logistic regression, adjusting for potential confounders.

Results

From 2009 to 2021, we included 1127 patients (528 European and 599 Asian). Recruitment occurred either through emergency settings or outpatient clinics, with most Asian patients recruited from outpatient clinics (65.8%) and most European patients from emergency settings (99.8%). Brain lesions were more frequent in European patients (29.2% versus 6.3%; odds ratio, 4.09 [95% CI, 2.66–6.30]). In a sensitivity analysis restricted to hospitalized patients (n = 651), the association persisted. Unfavorable 3-month outcomes (5.5% versus 1.7%; odds ratio, 3.01 [95% CI, 1.35–6.68]) and secondary RCVS (50.4% versus 10.9%; odds ratio, 7.09 [95% CI, 5.14–9.76]) were also associated with European residency.

Conclusions

RCVS presentations vary across regions, with higher lesion rates, more secondary forms, and worse outcomes in European patients. While these exploratory results may reflect selection bias from differing health care structures, further research is needed to determine the contribution of genetic, environmental, and societal factors.

---

### Complications of reversible cerebral vasoconstriction syndrome in relation to age [^78d52308]. Journal of Neurology (2023). Medium credibility.

Conclusion

Among adult patients with RCVS in France, rates and types of complications vary according to age. While young age was associated with CAD, increasing age predisposed for haemorrhagic complications. Larger multi-center studies are necessary to confirm possible age-specific presentations of RCVS and should consider age when developing prognostic scores helping to guide clinical decision-making.

---

### Misdiagnosis of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome in the emergency department [^40674b39]. Journal of the American Heart Association (2023). Medium credibility.

Background Cerebrovascular dysregulation syndromes, posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS), are challenging to diagnose because they are rare and require advanced neuroimaging for confirmation. We sought to estimate PRES/RCVS misdiagnosis in the emergency department and its associated factors. Methods and Results We conducted a retrospective cohort study of PRES/RCVS patients using administrative claims data from 11 states (2016–2018). We defined patients with a probable PRES/RCVS misdiagnosis as those with an emergency department visit for a neurological symptom resulting in discharge to home that occurred ≤ 14days before PRES/RCVS hospitalization. Proportions of patients with probable misdiagnosis were calculated, characteristics of patients with and without probable misdiagnosis were compared, and regression analyses adjusted for demographics and comorbidities were performed to identify factors affecting probable misdiagnosis. We identified 4633 patients with PRES/RCVS. A total of 210 patients (4.53% [95% CI, 3.97–5.17]) had a probable preceding emergency department misdiagnosis; these patients were younger (mean age, 48 versus 54 years; P < 0.001) and more often female (80.4% versus 69.3%; P < 0.001). Misdiagnosed patients had fewer vascular risk factors except prior stroke (36.3% versus 24.2%; P < 0.001) and more often had comorbid headache (84% versus 21.4%; P < 0.001) and substance use disorder (48.8% versus 37.9%; P < 0.001). Facility-level factors associated with probable misdiagnosis included smaller facility, lacking a residency program (62.2% versus 73.7%; P < 0.001), and not having on-site neurological services (75.7% versus 84.3%; P < 0.001). Probable misdiagnosis was not associated with higher likelihood of stroke or subarachnoid hemorrhage during PRES/RCVS hospitalization. Conclusions Probable emergency department misdiagnosis occurred in ≈1 of every 20 patients with PRES/RCVS in a large, multistate cohort.

---

### Retrospective analysis of 80 patients diagnosed with reversible cerebral vasoconstriction syndrome in the helsinki metropolitan area [^ec4407f8]. European Journal of Neurology (2025). Medium credibility.

Background and Purpose

Up to 80% of patients diagnosed with reversible cerebral vasoconstriction syndrome (RCVS) experience complications such as ischaemic stroke, intracerebral or subarachnoid haemorrhage or posterior reversible encephalopathy syndrome. The aim was to evaluate the incidence of complications in patients diagnosed with RCVS in our clinic.

Patients and Methods

All adult patients (age > 16years) diagnosed with RCVS at the Helsinki University Central Hospital during the period between 1 January 2016 and 31 December 2022 were retrospectively identified. Medical and follow-up data were collected from medical records.

Results

Eighty patients diagnosed with RCVS were identified, of whom four patients had parenchymal lesions such as ischaemic stroke, intracerebral haemorrhage, posterior cerebral encephalopathy syndrome, subarachnoid haemorrhage or combinations thereof.

Conclusion

The complication rate of RCVS is lower than in previously published cohorts. This may be related to better and earlier diagnostics and earlier withdrawal of possible triggers.

---

### Reversible cerebral vasoconstriction syndrome presenting with haemorrhage [^5aa93a0c]. Journal of the Neurological Sciences (2009). Low credibility.

Reversible cerebral vasoconstriction syndromes are characterized by prolonged but reversible vasoconstriction of the cerebral arteries, presenting typically with thunderclap headache, with or without focal neurological signs or symptoms. They resemble primary central nervous system vasculitis but it is critical to differentiate these two entities. Here we draw attention to intracranial haemorrhage as an important and not uncommon clinical feature in reversible cerebral vasoconstriction syndrome. Four patients with reversible cerebral vasoconstriction syndrome, each presenting to a single unit with intracranial haemorrhage, are described. These descriptions of haemorrhage at presentation of RCVS extend the recognised clinical phenotype and so help to enhance recognition and diagnosis of this often unconsidered disorder.

---

### Misdiagnosis of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome in the emergency department [^5870e00a]. Journal of the American Heart Association (2023). Medium credibility.

Clinical Perspective

Over the past few years, several cohort studies have characterized posterior reversible encephalopathy syndrome (PRES), and reversible cerebral vasoconstriction syndrome (RCVS), leading to an increased recognition of these 2 entities as cerebrovascular dysregulation syndromes with overlapping presenting symptoms and a shared pathophysiology of transiently impaired cerebral autoregulation. Despite our improved understating of these diseases, diagnosing PRES or RCVS is complicated by the relative rarity of these conditions, the need for advanced neuroimaging for confirmation, and the lack of well‐established diagnostic criteria for PRES/RCVS. Rates of misdiagnosis of these cerebrovascular dysregulation syndromes are not well quantified, though rates of misdiagnosis of other cerebrovascular diseases in the emergency setting range from 3% to 9%. Understanding current patterns of acute misdiagnosis among patients with PRES/RCVS is an essential first step toward improving diagnostic quality and safety for these patients. We therefore sought to evaluate rates of probable PRES/RCVS misdiagnosis in the emergency department (ED) at the population level. We also sought to identify patient‐ and facility‐level factors associated with misdiagnosis as well as to assess the impact of a probable ED misdiagnosis on subsequent clinical outcomes.

---

### Misdiagnosis of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome in the emergency department [^58bfd086]. Journal of the American Heart Association (2023). Medium credibility.

Background

Cerebrovascular dysregulation syndromes, posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS), are challenging to diagnose because they are rare and require advanced neuroimaging for confirmation. We sought to estimate PRES/RCVS misdiagnosis in the emergency department and its associated factors.

Methods and Results

We conducted a retrospective cohort study of PRES/RCVS patients using administrative claims data from 11 states (2016–2018). We defined patients with a probable PRES/RCVS misdiagnosis as those with an emergency department visit for a neurological symptom resulting in discharge to home that occurred ≤ 14 days before PRES/RCVS hospitalization. Proportions of patients with probable misdiagnosis were calculated, characteristics of patients with and without probable misdiagnosis were compared, and regression analyses adjusted for demographics and comorbidities were performed to identify factors affecting probable misdiagnosis. We identified 4633 patients with PRES/RCVS. A total of 210 patients (4.53% [95% CI, 3.97–5.17]) had a probable preceding emergency department misdiagnosis; these patients were younger (mean age, 48 versus 54 years; P < 0.001) and more often female (80.4% versus 69.3%; P < 0.001). Misdiagnosed patients had fewer vascular risk factors except prior stroke (36.3% versus 24.2%; P < 0.001) and more often had comorbid headache (84% versus 21.4%; P < 0.001) and substance use disorder (48.8% versus 37.9%; P < 0.001). Facility‐level factors associated with probable misdiagnosis included smaller facility, lacking a residency program (62.2% versus 73.7%; P < 0.001), and not having on‐site neurological services (75.7% versus 84.3%; P < 0.001). Probable misdiagnosis was not associated with higher likelihood of stroke or subarachnoid hemorrhage during PRES/RCVS hospitalization.

Conclusions

Probable emergency department misdiagnosis occurred in ≈1 of every 20 patients with PRES/RCVS in a large, multistate cohort.

---

### Long-term outcomes after reversible cerebral vasoconstriction syndrome [^fb119f56]. Stroke (2020). Medium credibility.

Background and Purpose- We aimed to further investigate the long-term outcomes after reversible cerebral vasoconstriction syndrome (RCVS). Methods- A longitudinal follow-up study was conducted in 173 RCVS patients. Results- Of the 172 patients who completed a mean follow-up of 9.2 ± 3.3 years, 10 had a recurrent RCVS that was benign in all. Independent predictors of relapse were having a history of migraine and having exercise as a trigger for thunderclap headache during initial RCVS. After new delivery, the rate of postpartum RCVS was 9%. Conclusions- Overall, long-term outcome after RCVS is excellent.

---

### RCVS: by clinicians for clinicians-a narrative review [^d4df0b9a]. Journal of Neurology (2023). Medium credibility.

Background/Objective

Reversible cerebral vasoconstriction syndrome may be underdiagnosed. It can be accompanied by various complications, mainly intracerebral hemorrhage and ischemic stroke. The clinical presentation of this condition varies according to its localization. The aims of this review are to raise awareness of the disease, especially in the presence of corresponding risk factors; to connect its precipitating factors, pathophysiology, and complications; and to compare various differential diagnoses of vasoconstriction.

Methods

A review of the literature in PubMed/MEDLINE and Google Scholar was conducted from May 1997 until May 2022.

Results

Reversible cerebral vasoconstriction syndrome, which is a clinical–radiological syndrome, is mainly characterized by the occurrence of thunderclap headache and widespread vasoconstriction. The most common precipitating factors are the use of vasoactive substances and postpartum status. The pathophysiology is currently assumed to include two mechanisms: sympathetic overactivity and endothelial dysfunction. From these mechanisms, it is possible to derive potential complications as well as the most important differential diagnoses: posterior reversible encephalopathy syndrome, convexity subarachnoid hemorrhage, ischemic and hemorrhagic stroke, and primary angiitis of the central nervous system.

Conclusion

In general, the outcome of reversible cerebral vasoconstriction syndrome is very good. Vasospasm as well as thunderclap headache attacks can be fully reversible, and > 90% of patients are functionally independent at discharge.

Supplementary Information

The online version contains supplementary material available at 10.1007/s00415-022-11425-z.

---

### Misdiagnosis of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome in the emergency department [^1816ad48]. Journal of the American Heart Association (2023). Medium credibility.

Measurements

We defined ED treat‐and‐release visits for neurological symptoms as those with a primary ICD‐10‐CM discharge diagnosis code for any neurological issue (eg, headache, numbness, dizziness, or altered mental status). ED visits in which a cerebrovascular condition was diagnosed were defined using well‐established ICD‐10‐CM codes.ED treat‐and‐release visits for a nonneurological symptom were defined as those with a primary ICD‐10‐CM discharge diagnosis code for any nonneurological issue (eg, chest pain, vomiting).

We used ICD‐10‐CM codes recorded at the time of PRES/RCVS hospitalization to measure the following vascular comorbidities: hypertension, diabetes, coronary artery disease, congestive heart failure, atrial fibrillation/flutter, chronic obstructive pulmonary disease, chronic kidney disease, renal failure, and prior stroke. We also used ICD‐10‐CM codes recorded at the time of PRES/RCVS hospitalization to measure the following comorbidities and triggers previously associated with PRES/RCVS: primary headache disorder, substance‐use disorder, drug poisoning, psychiatric illness, lupus, rheumatological disorders, cancer, and pregnancy/puerperium.

To explore the impact of probable misdiagnosis on patients' outcomes, we determined the frequency of ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage (SAH) using highly reliable ICD‐10‐CM diagnostic codes recorded at the PRES/RCVS hospitalization. We also calculated length of stay for PRES/RCVS hospitalization and recorded discharge disposition.

We used data from the American Hospital Association to determine each facility's bed size, teaching status, and availability of neurological services.

---

### RCVSscore and diagnostic approach for reversible cerebral vasoconstriction syndrome [^2e92e9df]. Neurology (2019). Medium credibility.

Objective

To develop a method to distinguish reversible cerebral vasoconstriction syndrome (RCVS) from other large/medium-vessel intracranial arteriopathies.

Methods

We identified consecutive patients from our institutional databases admitted in 2013–2017 with newly diagnosed RCVS (n = 30) or non-RCVS arteriopathy (n = 80). Admission clinical and imaging features were compared. Multivariate logistic regression modeling was used to develop a discriminatory score. Score validity was tested in a separate cohort of patients with RCVS and its closest mimic, primary angiitis of the CNS (PACNS). In addition, key variables were used to develop a bedside approach to distinguish RCVS from non-RCVS arteriopathies.

Results

The RCVS group had significantly more women, vasoconstrictive triggers, thunderclap headaches, normal brain imaging results, and better outcomes. Beta coefficients from the multivariate regression model yielding the best c -statistic (0.989) were used to develop the RCVS 2 score (range -2 to +10; recurrent/single thunderclap headache; carotid artery involvement; vasoconstrictive trigger; sex; subarachnoid hemorrhage). Score ≥ 5 had 99% specificity and 90% sensitivity for diagnosing RCVS, and score ≤ 2 had 100% specificity and 85% sensitivity for excluding RCVS. Scores 3–4 had 86% specificity and 10% sensitivity for diagnosing RCVS. The score showed similar performance to distinguish RCVS from PACNS in the validation cohort. A clinical approach based on recurrent thunderclap headaches, trigger and normal brain scans, or convexity subarachnoid hemorrhage correctly diagnosed 25 of 37 patients with RCVS 2 scores 3–4 across the derivation and validation cohorts.

Conclusion

RCVS can be accurately distinguished from other intracranial arteriopathies upon admission, using widely available clinical and imaging features.

Classification Of Evidence

This study provides Class II evidence that the RCVS 2 score accurately distinguishes patients with RCVS from those with other intracranial arteriopathies.

---

### Retrospective analysis of 80 patients diagnosed with reversible cerebral vasoconstriction syndrome in the helsinki metropolitan area [^2ef0e712]. European Journal of Neurology (2025). Medium credibility.

Abstract

Background and purpose

Up to 80% of patients diagnosed with reversible cerebral vasoconstriction syndrome (RCVS) experience complications such as ischaemic stroke, intracerebral or subarachnoid haemorrhage or posterior reversible encephalopathy syndrome. The aim was to evaluate the incidence of complications in patients diagnosed with RCVS in our clinic.

Patients and methods

All adult patients (age > 16 years) diagnosed with RCVS at the Helsinki University Central Hospital during the period between 1 January 2016 and 31 December 2022 were retrospectively identified. Medical and follow‐up data were collected from medical records.

Results

Eighty patients diagnosed with RCVS were identified, of whom four patients had parenchymal lesions such as ischaemic stroke, intracerebral haemorrhage, posterior cerebral encephalopathy syndrome, subarachnoid haemorrhage or combinations thereof.

Conclusion

The complication rate of RCVS is lower than in previously published cohorts. This may be related to better and earlier diagnostics and earlier withdrawal of possible triggers.

---

### Characteristics and demographics of reversible cerebral vasoconstriction syndrome: a large prospective series of Korean patients [^e08af022]. Cephalalgia (2018). Low credibility.

Objectives To report demographics and characteristics of reversible cerebral vasoconstriction syndrome (RCVS) in the Korean cohort. Methods We prospectively recruited patients with definite (imaging-proven) RCVS and probable (imaging-negative) RCVS who visited Samsung Medical Center between June 2012 and September 2016. Clinical manifestations, neuroimaging, treatment, and clinical outcomes were evaluated in all patients. Characteristics of RCVS without typical causes ("idiopathic RCVS") were compared with those of RCVS with identifiable causes ("secondary RCVS"). International Classification of Headache Disorders (ICHD)-3 beta criteria for 6.7.3 RCVS and 6.7.3.1 probable RCVS were tested. Results A total of 138 patients (104 definite and 34 probable RCVS) were included in this study. Patients with definite RCVS were predominantly female (85.6%) and middle-aged (mean, 50.7 [range, 23–82] years). Probable RCVS was associated with less female predominance (70.6%, p = 0.049), more typical manifestations (p < 0.001), and none of neurological complications. One-hundred and one (97.1%) patients with definite RCVS had headache, but the typical "recurrent and/or triggered" thunderclap headache was reported in only 83 (82.2%). In most patients with definite RCVS (84.6%), RCVS was idiopathic, while only 16 (15.4%) had secondary causes. Compared to those with secondary RCVS, patients with idiopathic RCVS were older (52.8 ± 11.42 vs. 39.1 ± 9.55 years, p < 0.001). Patients with secondary RCVS had more complications than those with idiopathic RCVS (40.5% vs. 12.5%, p = 0.018). Among idiopathic RCVS patients, 33 (37.5%) reported a preceding event or a change in lifestyle, environment, health, or medication within one month before onset. Conclusion In our cohort, RCVS was benign and idiopathic in most patients, and occurred frequently in middle-aged women. Manifestations of RCVS were more diverse than previously recognized, and forms without any headache existed. Different genetic, social, and environmental factors should be taken into account to unveil the spectrum and pathophysiology of RCVS.

---

### Reversible cerebral vasoconstriction syndrome intERnational collaborativE (REVERCE) network: study protocol and rationale of a multicentre research collaboration [^74797bce]. European Stroke Journal (2023). Medium credibility.

Baseline variables

Data for each individual patient are collected from the hospital at index event or at outpatient clinic evaluation. Baseline data include demographic characteristics, medical history and medication used on admission, potential precipitating and triggering factors, diagnostic workup (i.e. vascular and brain imaging, blood analyses, CSF analyses) and treatment. Cardiovascular risk factors and comorbidities as definedinwill be documented.

Precipitating factors for RCVS and triggers for headache episodes

We will collect detailed information on precipitating conditions and triggers for headache. In case of specific precipitating factors with a clear temporal association, RCVS will be qualified as secondary or idiopathic. – A temporal association will generally be considered if the precipitating condition occurred within 4 weeks prior to RCVS onset, with exception for drugs and medications with a longer half-life. Postpartum RCVS mainly occurs during the first month after delivery, but might occur later as previously described for late onset postpartum eclampsia. Therefore, in RCVS occurring later than 4 weeks after delivery, postpartum will be considered as precipitating factor on a case-by-case basis and validated by two members of the steering committee. Remote emotional stress (e.g. serious illness of a family member, work overload) within 4 weeks prior to onset of RCVS will be documented, but not classified as a cause for secondary RCVS. If triggers for headache episodes (e.g. exertion, sexual activity) are reported, but there is no precipitating condition, RCVS is considered idiopathic.

Clinical features

We will retain data on headache characteristics and any neurological symptoms. In particular, information on duration of symptoms prior to establishment of diagnosis, date of established diagnosis, presence of clinical complications (i.e. transient deficit (aura-like or transient ischaemic attack-like), persistent deficit, and seizure), and treatment will also be collected. At baseline, the severity of stroke (if any) is assessed with the National Institutes of Health Stroke Scale (NIHSS) scoreand the functional neurological outcome by the modified Ranking Scale (mRS).

---

### Grief-induced reversible cerebral vasoconstriction syndrome (RCVS) [^6c8d8e51]. BMJ Case Reports (2020). High credibility.

Background

Reversible cerebral vasoconstriction syndrome (RCVS) is a group of conditions that are caused by reversible multifocal narrowing of the cerebral arteries with clinical manifestations that can include headache, stroke and seizure.

The pathophysiology of RCVS remains unclear. Female predominance may suggest hormonal influences, particularly given the increased risk during pregnancy and the postpartum period. Increased sympathomimetic activity triggered by sexual activity, ingestion of sympathomimetic drugs and the increased incidence of RCVS in patients with a prior history of serotonergic antidepressant use could alternatively suggest biochemical triggers. Identification of aetiologies that could potentially lead to RCVS, such as severe emotional stress, may help to further our understanding of the pathophysiology of this disease.

---

### Complications of reversible cerebral vasoconstriction syndrome in relation to age [^73d754ad]. Journal of Neurology (2023). Medium credibility.

Introduction

Reversible cerebral vasoconstriction syndrome (RCVS) has a heterogenous clinical and radiological presentation. We investigated whether RCVS complications vary according to age.

Patients and methods

In a pooled French cohort of 345 patients with RCVS, we assessed (1) rates of clinical and radiological complications, and (2) the functional outcome at 3 months according to age as a continuous variable, and in young patients aged ≤ 49 years versus those aged ≥ 50 years. The Commission Nationale Informatique et Liberté and the local ethics committee approved this study (registration number: 202100733).

Results

The risk for any focal deficit and for any brain lesion were independently associated with increasing age (OR 1.4, 95% CI 1.1–1.8; p = 0.014, and OR 1.6, 95% CI 1.2–2.1; p < 0.001, respectively). Subtypes of brain lesions independently associated with increasing age were subarachnoid haemorrhage (OR 1.7, 95% CI 1.3–2.3; p < 0.001) and intracerebral haemorrhage (OR 1.5, 95% CI 1.1–2.2; p = 0.023). Frequency of cervical artery dissections peaked at age 30–39, and young age was independently associated with cervical artery dissections (OR 13.6, 95% CI 2.4–76.6; p = 0.003). Age had no impact on the functional outcome, with a modified Rankin scale score of 0–1 in > 96% of patients.

Conclusion

Age seems to influence rates and types of complications of RCVS, with young age being associated with cervical artery dissections, and increasing age with haemorrhagic complications. If confirmed in larger prospective studies, recognition of age-specific patterns might help to guide clinical management and to identify complications in cases of RCVS and vice versa.

Supplementary Information

The online version contains supplementary material available at 10.1007/s00415-023-11708-z.

---

### Clinical worsening in reversible cerebral vasoconstriction syndrome [^981b6454]. JAMA Neurology (2014). Medium credibility.

Importance

Reversible cerebral vasoconstriction syndrome (RCVS) is characterized by recurrent thunderclap headaches and evidence of vasoconstriction with subsequent resolution. The clinical course of RCVS is traditionally considered monophasic and benign. However, recurrent episodes of focal neurological symptoms have been described after initial presentation.

Objective

To define the frequency, timing, and consequences of clinical worsening in patients with diagnosis of RCVS.

Design, Setting, and Participants

Retrospective observational study of consecutive patients with RCVS at 2 referral institutions for neurological disease.

Main Outcome and Measure

Clinical worsening after diagnosis of RCVS. We defined clinical worsening as new permanent or transient neurological deficits (compared with presenting signs and symptoms) or new onset of seizures. We performed a logistic regression analysis to assess associations between patient characteristics and clinical worsening. Functional outcome was assessed at 1 to 3 months using the modified Rankin score.

Results

We identified 59 patients (median age, 47 years; interquartile range, 32–54 years) with RCVS. Twenty patients (34%) experienced clinical worsening after a median of 2.5 days (range, several hours to 14 days). Eight of the 20 patients who worsened had permanent deficits, including 4 who died. We did not find an association between age, sex, smoking, migraine, acute or chronic hypertension, peripartum state, or use of serotonergic drugs with clinical worsening. Clinical worsening was associated with radiological infarction (P = 0.001) and worse functional outcome (P < .004). Functional outcome was favorable (modified Rankin score 0–2) in 51 patients (86.4%).

Conclusions and Relevance

Clinical worsening after diagnosis is common in patients with RCVS. Thus, RCVS is self-limited but not strictly monophasic. Most patients have a very favorable outcome, but clinical worsening may result in permanent deficits.

---

### Complications of reversible cerebral vasoconstriction syndrome in relation to age [^534a231d]. Journal of Neurology (2023). Medium credibility.

The main limitation of our study consists in the retrospective data acquisition for cohorts B and C. Further, although we describe the largest European cohort to date, the numbers for some subtypes of complications remain small. This possibly contributes to the inconsistency of findings between the different cohorts published to date, and future larger multi-centric studies could be suited to confirm or refute clinical and radiological predictors of complications and of an unfavourable functional outcome. Moreover, since we included only adult patients aged ≥ 15 years from two French hospitals, our findings may not be applicable to other populations and to pediatric patients. Finally, we have not compared the localisation, degree and number of vasospasms, possibly varying according to age and influencing the risk for complications.

---

### Migraines during pregnancy linked to stroke and vascular diseases: US population based case-control study [^98e38280]. BMJ (2009). Excellent credibility.

In addition, we were unable to distinguish between migraine with aura (ICD-9 346.0) and without aura (346.11), as a very small proportion of migraines were coded in this fashion and most were coded 346.9 (data not shown). This may have led to an underestimation of the association, as most other studies have shown that the association between migraine and cardiovascular disease was limited to migraine with aura. In non-pregnant women of childbearing age, the Stroke Prevention in Young Women Study showed that women with visual aura had a 50% higher risk of ischaemic stroke, similar to studies of older women. For all the reasons stated, these results need to be validated with review of medical records for ICD-9 diagnoses during pregnancy related admissions.

Some diagnoses of peripartum migraine could have been miscoded or inadvertently listed separately in the setting of cerebrovascular complications in which headache is a prominent symptom. About 50–55% of patients with intracerebral haemorrhage and 25% with ischaemic stroke may present with headache. In addition, ischaemic strokes can also cause migraine. Although 78–91% of patients with cerebral venous thrombosis present with headache, we are uncertain of the specific association because these events were most likely coded as 674.0 (pregnancy related cerebrovascular event). Other complications that often involve headache include severe pre-eclampsia/eclampsia and the accompanying vasculopathy involving vasogenic oedema (posterior reversible encephalopathy syndrome) or postpartum angiopathy (reversible cerebral vasoconstriction occurring postpartum with or without elevated blood pressure). Confirmation by review of medical records or prospective studies would clarify how often the presenting stroke symptoms lead to misdiagnosis of migraine.

---

### Fatal reversible cerebral vasoconstriction syndrome [^8dd4f026]. Journal of the Neurological Sciences (2018). Low credibility.

We report four fatal cases of fulminant reversible cerebral vasoconstriction syndrome, all initially diagnosed as primary central nervous system vasculitis and treated with corticosteroids. Although reversible cerebral vasoconstriction syndrome is usually self-limiting without permanent neurologic deficits, rarely it can be fatal and worse outcomes have been associated with corticosteroid treatment.

---

### Misdiagnosis of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome in the emergency department [^4a605395]. Journal of the American Heart Association (2023). Medium credibility.

Table 1
Differences Between Patients With Versus Without Probable Posterior Reversible Encephalopathy Syndrome/Reversible Cerebral Vasoconstriction Syndrome Misdiagnosis Weighted Using Visit Frequency

In Table 2, facility factors associated with a probable ED misdiagnosis are reported. We found that probable misdiagnosis was associated with presenting to a facility without an Accreditation Council for Graduate Medical Education–approved residency program (62.2% versus 70.4%; P = 0.006), to a facility without neurological services (75.7% versus 81.2%; P = 0.032), and to a facility that was smaller in size. Due to a lack of hospital‐level identifiers for certain states in HCUP, facility‐level information was unavailable for 30 of 281 (10.7%) ED encounters among patients with a probable misdiagnosis and 717 of 4485 (16%) encounters among correctly diagnosed patients. In our multivariable model including both patient and facility factors, we found that comorbid headache at the time of PRES/RCVS hospitalization was most associated with probable ED misdiagnosis (OR, 15.21 [95% CI, 10.34–22.38]).

Table 2
Facility‐Level Differences Between Emergency Department Encounters With Versus Without Probable Posterior Reversible Encephalopathy Syndrome/Reversible Cerebral Vasoconstriction Syndrome Misdiagnosis

After adjustment for demographics and all comorbidities, probable misdiagnosis was not significantly associated with ischemic stroke (OR, 1.33 [95% CI, 0.75–2.35]), intracerebral hemorrhage (OR, 1.18 [95% CI, 0.57–2.45]), or SAH (OR, 1.28 [95% CI, 0.76–2.17]) documented during the PRES/RCVS hospitalization. Probable misdiagnosis was negatively related to length of stay such that the average length of stay was 2 days shorter for patients with a probable misdiagnosis after adjustment for demographics and comorbidities (P = 0.003). There was no statistically significant association between probable misdiagnosis and discharge destination (OR, 0.71 [95% CI, 0.49–1.02]) after adjustment.

---

### Misdiagnosis of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome in the emergency department [^ce4738ba]. Journal of the American Heart Association (2023). Medium credibility.

Results

We identified 4633 patients hospitalized for PRES/RCVS; most (n = 4169; 90.0%) had PRES. A total of 210 patients (4.5% [95% CI, 4.0–5.2]) had a probable ED misdiagnosis. A total of 615 patients (13.3% [95% CI, 12.3–14.3) had a possible ED misdiagnosis.

Among the 210 patients with a probable misdiagnosis, there were 281 ED treat‐and‐release visits in the 14 days before their PRES/RCVS hospitalization. There were 50 patients with a probable misdiagnosis who had > 1 ED treat‐and‐release visit before their PRES/RCVS hospitalization; the median number of preceding ED visits was 1 (interquartile range, 1–2). The 3 most common ED treat‐and‐release visits' primary diagnoses among patients with a probable misdiagnosis were headache, migraine headache, and unspecified altered mental status. ED visit frequency increased closer in time to the PRES/RCVS hospitalization; there were 51 relevant ED visits ≤ 1 day before PRES/RCVS hospitalization as opposed to only 17 visits on the 14th day before PRES/RCVS hospitalization (P < 0.001; Figure).

---

### Serial testing of the ICHD-3 beta diagnostic criteria for probable reversible cerebral vasoconstriction syndrome: a prospective validation study [^4a753e55]. Cephalalgia (2018). Low credibility.

Objectives To serially test the International Classification of Headache Disorders (ICHD) 3rd edition beta version criteria for 6.7.3.1 probable reversible cerebral vasoconstriction syndrome (probable RCVS) in patients with thunderclap headache. Methods We prospectively screened consecutive patients with thunderclap headache who visited the Samsung Medical Center between October 2015 and March 2017. Patients were included in the analysis if they a) visited our hospital within 1 month after onset, b) completed a diagnostic work-up, and c) had no secondary causes other than RCVS. The ICHD-3 beta 6.7.3.1 criteria were evaluated serially during the first visit (visit 1), 2 weeks after the first visit (visit 2), and 1–3 months after onset (visit 3). Results A total of 99 patients completed this study. Based on the first clinical and radiological evaluation, 63 (63.6%) were diagnosed with angiogram-proven RCVS, whilst 36 (36.4%) showed normal neuroimaging. The ICHD-3 beta 6.7.3.1 criteria were fulfilled in 76.2% of patients with angiogram-proven RCVS. In patients with normal angiograms, the ICHD diagnosis of probable RCVS changed over time: 25.0%, 47.2%, and 38.9% at visits 1, 2, and 3, respectively. The sensitivity and specificity of the criteria at visit 1 were 72.4% and 95.5%, respectively, for the prediction of a final diagnosis of overall (angiogram-proven+probable) RCVS. Conclusions The ICHD-3 beta criteria for probable RCVS are applicable for patients with thunderclap headaches at the acute stage, with the exception of criterion C3. Criteria C1 and C2 are less reliable when applied at the first visit. Repeated evaluation is necessary to enhance diagnostic sensitivity.

---

### Reversible cerebral vasoconstriction syndrome [^fa949d9e]. The Lancet: Neurology (2012). Medium credibility.

Recurrent thunderclap headaches, seizures, strokes, and non-aneurysmal subarachnoid haemorrhage can all reveal reversible cerebral vasoconstriction syndrome. This increasingly recognised syndrome is characterised by severe headaches, with or without other symptoms, and segmental constriction of cerebral arteries that resolves within 3 months. Reversible cerebral vasoconstriction syndrome is supposedly due to a transient disturbance in the control of cerebrovascular tone. More than half the cases occur post partum or after exposure to adrenergic or serotonergic drugs. Manifestations have a uniphasic course, and vary from pure cephalalgic forms to rare catastrophic forms associated with several haemorrhagic and ischaemic strokes, brain oedema, and death. Diagnosis can be hampered by the dynamic nature of clinicoradiological features. Stroke can occur a few days after initial normal imaging, and cerebral vasoconstriction is at a maximum on angiograms 2–3 weeks after clinical onset. The calcium channel blocker nimodipine seems to reduce thunderclap headaches within 48 h of administration, but has no proven effect on haemorrhagic and ischaemic complications.

---

### Complications of reversible cerebral vasoconstriction syndrome in relation to age [^e2ab3462]. Journal of Neurology (2023). Medium credibility.

Introduction

Reversible cerebral vasoconstriction syndrome (RCVS) has a heterogenous clinical and radiological presentation. We investigated whether RCVS complications vary according to age.

Patients and Methods

In a pooled French cohort of 345 patients with RCVS, we assessed (1) rates of clinical and radiological complications, and (2) the functional outcome at 3 months according to age as a continuous variable, and in young patients aged ≤ 49 years versus those aged ≥ 50 years. The Commission Nationale Informatique et Liberté and the local ethics committee approved this study (registration number: 202100733).

Results

The risk for any focal deficit and for any brain lesion were independently associated with increasing age (OR 1.4, 95% CI 1.1–1.8; p = 0.014, and OR 1.6, 95% CI 1.2–2.1; p < 0.001, respectively). Subtypes of brain lesions independently associated with increasing age were subarachnoid haemorrhage (OR 1.7, 95% CI 1.3–2.3; p < 0.001) and intracerebral haemorrhage (OR 1.5, 95% CI 1.1–2.2; p = 0.023). Frequency of cervical artery dissections peaked at age 30–39, and young age was independently associated with cervical artery dissections (OR 13.6, 95% CI 2.4–76.6; p = 0.003). Age had no impact on the functional outcome, with a modified Rankin scale score of 0–1 in > 96% of patients.

Conclusion

Age seems to influence rates and types of complications of RCVS, with young age being associated with cervical artery dissections, and increasing age with haemorrhagic complications. If confirmed in larger prospective studies, recognition of age-specific patterns might help to guide clinical management and to identify complications in cases of RCVS and vice versa.

---

### Posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome in patients with COVID-19 infection: is there a link? A systematic review and case report analysis [^c2dfdff9]. Journal of Neurology (2023). Medium credibility.

During the SARS-CoV2 pandemic, several cases of Posterior Reversible Encephalopathy Syndrome (PRES) and of Reversible Cerebral Vasoconstriction Syndrome (RCVS) in COVID-19 patients have been reported, but the link between these syndromes and COVID-19 is unclear. We performed a systematic review, according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement to evaluate whether SARS-CoV2 infection or the drugs used to treat it could be deemed potential risk factors for PRES or RCVS. We performed a literature search. We found 70 articles (60 on PRES and 10 on RCVS) concerning n = 105 patients (n = 85 with PRES, n = 20 with RCVS). We analyzed the clinical characteristics of the two populations separately, then performed an inferential analysis to search for other independent risk factors. We found fewer than usual PRES-related (43.9%) and RCVS-related (45%) risk factors in patients with COVID-19. Such a low incidence of risk factors for PRES and RCVS might suggest the involvement of COVID-19 as an additional risk factor for both diseases due to its capability to cause endothelial dysfunction. We discuss the putative mechanisms of endothelial damage by SARS-CoV2 and antiviral drugs which may underlie the development of PRES and RCVS.

---

### Misdiagnosis of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome in the emergency department [^930d1a17]. Journal of the American Heart Association (2023). Medium credibility.

Methods

We followed the Strengthening the Reporting of Observational Studies in Epidemiology guidelines. The data that support the findings of this study are publicly available from the Healthcare Cost and Utilization Project (HCUP) at.

Design

We conducted a retrospective cohort study of patients with PRES, RCVS, or both using deidentified all‐payer claims data from all nonfederal EDs and hospitals across 11 states. These data were obtained from the Agency for Healthcare Research and Quality and its HCUP database. The included states were Arkansas, Florida, Georgia, Iowa, Massachusetts, Maryland, Nebraska, New York, Utah, Vermont, and Wisconsin. These 11 states were chosen because they are the only ones that provide contemporary longitudinal data to HCUP, thereby enabling tracking of patients across multiple ED visits and hospital admissions using an anonymous personal linkage number. This study was conducted from 2016 to 2018. The Weill Cornell Medicine Institutional Review Board approved this study and granted a waiver of informed consent.

In this study, we used the National Academies of Sciences, Engineering, and Medicine definition of diagnostic error as a failure to establish an accurate and timely explanation of a patient's health problem. In keeping with prior research, we defined a probable misdiagnosis of PRES/RCVS as when (1) an ED visit resulted in discharge to home (treat‐and‐release visit), (2) the primary ED discharge diagnosis was for a neurological symptom (eg, headache, dizziness, numbness) that could represent an early manifestation of PRES/RCVS, and (3) the ED discharge occurred in the 14 days before the PRES/RCVS hospitalization. We defined a possible ED misdiagnosis as any ED treat‐and‐release visit during the 14 days before a PRES/RCVS hospitalization because PRES/RCVS can initially manifest with systemic complaints (eg, elevated blood pressure). All other patients were considered as not having evidence of ED misdiagnosis (not misdiagnosed); patients with a cerebrovascular event during the 14 days before PRES/RCVS hospitalization were also considered not misdiagnosed, as these events can coincide with PRES/RCVS.

---

### The clinical spectrum of reversible cerebral vasoconstriction syndrome: the Italian project on stroke at young age (IPSYS) [^174bee71]. Cephalalgia (2019). Medium credibility.

Introduction

To describe clinical, neuroimaging, and laboratory features of a large cohort of Italian patients with reversible cerebral vasoconstriction syndrome.

Methods

In the setting of the multicenter Italian Project on Stroke at Young Age (IPSYS), we retrospectively enrolled patients with a diagnosis of definite reversible cerebral vasoconstriction syndrome according to the International Classification of Headache Disorders (ICHD)-3 beta criteria (6.7.3 Headache attributed to reversible cerebral vasoconstriction syndrome, imaging-proven). Clinical manifestations, neuroimaging, treatment, and clinical outcomes were evaluated in all patients. Characteristics of reversible cerebral vasoconstriction syndrome without typical causes ("idiopathic reversible cerebral vasoconstriction syndrome") were compared with those of reversible cerebral vasoconstriction syndrome related to putative causative factors ("secondary reversible cerebral vasoconstriction syndrome").

Results

A total of 102 patients (mean age, 47.2 ± 13.9 years; females, 85 [83.3%]) qualified for the analysis. Thunderclap headache at presentation was reported in 69 (67.6%) patients, and it typically recurred in 42 (60.9%). Compared to reversible cerebral vasoconstriction syndrome cases related to putative etiologic conditions (n = 21 [20.6%]), patients with idiopathic reversible cerebral vasoconstriction syndrome (n = 81 [79.4%]) were significantly older (49.2 ± 13.9 vs. 39.5 ± 11.4 years), had more frequently typical thunderclap headache (77.8% vs. 28.6%) and less frequently neurological complications (epileptic seizures, 11.1% vs. 38.1%; cerebral infarction, 6.1% vs. 33.3%), as well as concomitant reversible brain edema (25.9% vs. 47.6%).

Conclusions

Clinical manifestations and putative etiologies of reversible cerebral vasoconstriction syndrome in our series are slightly different from those observed in previous cohorts. This variability might be partly related to the coexistence of precipitating conditions with a putative etiologic role on disease occurrence.

---

### Clinical features, imaging findings and outcomes of headache associated with sexual activity [^132315cf]. Cephalalgia (2010). Low credibility.

Objectives

To study the clinical profiles, imaging findings and outcomes and field test the diagnostic criteria proposed by the International Classification of Headache Disorders, 2nd edition (ICHD-II) in patients with headache associated with sexual activity (HSA).

Methods

We recruited 30 patients (16 men, 14 women, mean age at onset 40.2 ± 10.0 years) with headache associated with sexual activity at a headache clinic from 2004 to 2009. None of the patients had neurological deficits at onset.

Results

Twenty patients (67%) had secondary causes, including one subarachnoid hemorrhage, one basilar artery dissection, and 18 cases reversible cerebral vasoconstriction syndrome (RCVS). Ten patients (33%) had primary HSA. The demographics, headache profiles, drug response and clinical course were similar between primary and secondary HSA. Compared to prior studies done in Western societies, our patients had similar clinical features but with a higher ratio of females (50%) and a higher frequency of chronic course (39%).

Discussion

Sixty-seven percent of patients with RCVS could not fulfill the criteria of reversible angiopathy of the central nervous system (Code 6.7.3) proposed by the ICHD-II. The most common reason was headache resolution in more than two months. In addition, 40% of patients with primary HSA could not fulfill the ICHD-II criteria for primary HSA (Code 4.4).

Conclusions

Our study found that intracranial vascular disorders were very common in patients with HSA. Thorough neurovascular imaging is required for all patients with HSA.

---

### Reversible cerebral vasoconstriction syndrome: is it more than just cerebral vasoconstriction? [^cfe34c79]. Cephalalgia (2015). Low credibility.

Background

Systemic vascular alterations have not been described in reversible cerebral vasoconstriction syndrome (RCVS). We present a case series of RCVS patients having cardiac dysfunction during ictus, with a subset showing complete resolution of cardiomyopathy.

Methods

Retrospective case-series: Cardiac left ventricular ejection fraction (LVEF) and wall motion abnormalities (WMA) visualized on transthoracic echocardiography (TTE), performed during RCVS ictus and follow-up was analyzed.

Results

Of 68 patients, 18 (26%) had a TTE performed around ictus. Three of 18 (17%) patients demonstrated WMA on initial TTE. All three patients were female without previous coronary artery disease or heart failure, and were asymptomatic from the cardiac dysfunction. WMA resolved completely on follow-up in Patients 1 and 2. Global LV dysfunction persisted for at least 90 days in Patient 3.

Conclusion

Although the exact pathophysiology of the cardiomyopathy is uncertain, it may be related to localized coronary vasoconstriction causing myocardial ischemia/infarction. Vasoconstriction may not be limited to the cerebral vasculature and may involve extracerebral organs. Cardiac ventricular abnormalities may be a part of the RCVS spectrum.

---

### Reversible cerebral vasoconstriction syndrome: rare or underrecognized in children? [^362908a9]. Developmental Medicine and Child Neurology (2013). Low credibility.

Reversible cerebral vasoconstriction syndrome (RCVS) is a clinicoradiological diagnosis comprising 'thunderclap' headaches and reversible segmental vasoconstriction of cerebral arteries, occasionally complicated by ischaemic or haemorrhagic stroke. We report a case of RCVS in a 13-year-old male with severe thunderclap headaches and no focal neurological signs. Brain imaging showed multiple posterior circulation infarcts; cerebral computed tomography, magnetic resonance imaging, and catheter angiography showed multifocal irregularity and narrowing, but in different arterial segments. Laboratory studies did not support a diagnosis of vasculitis. Symptoms resolved over 3 weeks; magnetic resonance angiography 3 months later was normal and remained so after 2 years. We highlight the typical clinical features of RCVS in this case and suggest that the diagnosis should be considered in children with thunderclap headaches or stroke syndromes where headache is a prominent feature, especially if cerebrovascular imaging studies appear to be evolving or discrepant.

---

### Reversible cerebral vasoconstriction syndrome intERnational collaborativE (REVERCE) network: study protocol and rationale of a multicentre research collaboration [^149d7043]. European Stroke Journal (2023). Medium credibility.

Introduction

Reversible cerebral vasoconstriction syndrome (RCVS) is a clinico-radiological entity with reversible multifocal narrowing of the cerebral arteries, typically acute severe headache and sometimes neurological deficits or seizure. RCVS has been proposed as the unifying term for several conditions including Call-Fleming syndrome, benign angiopathy of the CNS, postpartum angiopathy, and drug-induced arteritis. Diagnostic criteria include angiographically confirmed, multifocal, segmental cerebral artery vasoconstriction, no evidence of aneurysmal SAH, a (near-) normal CSF profile, severe acute headaches (often with the characteristics of thunderclap headaches (TCH)with or without focal neurological deficits or seizures), and reversibility of angiographic findings within 12 weeks. – Since publication of these criteria, it has been recognised that rarely, RCVS may occur without headache or in patients in whom information about headache is not available (e.g. due to coma, or severe aphasia). The clinical and radiologic spectrum of RCVS from pure cephalalgic forms to complications, including ischaemic and haemorrhagic lesions, and posterior encephalopathy syndrome (PRES). – Prevalence of complications varies and is higher among cohorts from Western countries than in Asian cohorts. – Despite a heterogeneous clinical presentation, the distinction between RCVS and its most feared differential diagnoses, namely primary angiitis of the central nervous system (PACNS) and vasospasm from aneurysmal SAH, is most often simple. –

---

### Misdiagnosis of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome in the emergency department [^f60ba0fa]. Journal of the American Heart Association (2023). Medium credibility.

Our study has a number of additional limitations. To begin with, it is possible that we may have underestimated the rate of PRES/RCVS misdiagnosis in the ED because we did not capture patients who failed to return for medical evaluation after an ED visit, patients who were never correctly diagnosed with PRES/RCVS when they returned, and patients who died before an accurate diagnosis could be made. Alternatively, we may have overestimated rates of misdiagnosis as some ED treat‐and‐release visits in the 14 days before PRES/RCVS hospitalization may have been completely unrelated to cerebrovascular dysregulation. However, this latter possibility seems unlikely given the temporal relationships we found between encounters. Second, we may have overestimated the number of patients diagnosed with PRES/RCVS in a timely and accurate fashion because we considered any patients without an ED treat‐and‐release visit in the 14 days before PRES/RCVS hospitalization to be correctly diagnosed. It is possible that some of the patients we categorized as correctly diagnosed may have had a delayed diagnosis of PRES/RCVS during their hospitalization or may have been initially misdiagnosed at a non‐ED encounter (eg, outpatient office visit, urgent care visit) or initially presented to an ED in a state not included in our HCUP database. Third, given the relative rarity of probable ED misdiagnosis that we found, our study is likely underpowered. Fourth, missing information regarding facility‐level factors may have biased our results regarding which factors were associated with diagnostic error, as some states systematically lacked data regarding facilities. Finally, it is important to note that medication and imaging data were not available in HCUP, which limits our ability to fully characterize our study cohort.

---

### Retrospective analysis of 80 patients diagnosed with reversible cerebral vasoconstriction syndrome in the helsinki metropolitan area [^26368661]. European Journal of Neurology (2025). Medium credibility.

INTRODUCTION

Reversible cerebral vasoconstriction syndrome (RCVS) has been increasingly recognized after proposal of the name in 2007. RCVS has been previously described since 1970 as isolated benign cerebral vasculitis, acute benign cerebral angiopathy, Call–Fleming syndrome, reversible cerebral segmental vasoconstriction or central nervous system (CNS) pseudovasculitis.

RCVS typically presents with sudden and severe headaches, often described as thunderclap headache (TCH), which may be accompanied by focal neurological symptoms. Imaging techniques, such as computed tomography angiography (CTA) and magnetic resonance angiography (MRA), commonly reveal diffuse vasoconstriction of intracerebral arteries, which usually resolves within 3 months. There is evidence that the vasoconstriction starts in the distal small arteries and progresses gradually to more proximal and larger arteries during the disease course. Centripetal propagation of vasoconstriction on magnetic resonance imaging (MRI) acquired at the time of TCH remission is an indicator of RCVS severity.

RCVS can be provoked by exposure to certain drugs, including sympathomimetic drugs, serotonergic drugs, immunosuppressants, immunomodulators, oral contraceptives, illicit drugs such as cocaine and ecstasy, and other agents. Other conditions that are associated with RCVS are postpartum state, carotid stenting, open neurosurgical procedures, Takotsubo cardiomyopathy, thyrotoxicosis and pheochromocytoma.

No randomized control trials have been conducted for treatment of RCVS. Current recommendations are based on expert opinion and observational data. Empirical treatment with calcium channel blockers is frequently used. It is recommended to discontinue serotonergic and noradrenergic antidepressants, hormonal agents, immunosuppressive medications and immunomodulators. Additionally, exposure to other triggers should be avoided. Glucocorticoids and triptans should be avoided, whilst non‐steroidal anti‐inflammatory drugs and opioids can be used to reduce headaches.

---

### Reversible cerebral vasoconstriction syndrome, part 2: diagnostic work-up, imaging evaluation, and differential diagnosis [^0c8b5c73]. AJNR: American Journal of Neuroradiology (2015). Low credibility.

The diagnostic evaluation of a patient with reversible cerebral vasoconstriction syndrome integrates clinical, laboratory, and radiologic findings. Imaging plays an important role by confirming the presence of cerebral vasoconstriction; monitoring potential complications such as ischemic stroke; and suggesting alternative diagnoses, including CNS vasculitis and aneurysmal subarachnoid hemorrhage. Noninvasive vascular imaging, including transcranial Doppler sonography and MR angiography, has played an increasingly important role in this regard, though conventional angiography remains the criterion standard for the evaluation of cerebral artery vasoconstriction. Newer imaging techniques, including high-resolution vessel wall imaging, may help in the future to better discriminate reversible cerebral vasoconstriction syndrome from primary angiitis of the CNS, an important clinical distinction.

---

### Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222 [^ff93bde8]. Obstetrics and Gynecology (2020). High credibility.

Posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome — key neurologic mimics/associations in preeclampsia/eclampsia are described: PRES presents with neurologic signs such as vision loss or deficit, seizure, headache, and altered sensorium or confusion, with diagnosis based on vasogenic edema and posterior brain hyperintensities on magnetic resonance imaging; women are particularly at risk in the settings of eclampsia and preeclampsia with headache, altered consciousness, or visual abnormalities. Reversible cerebral vasoconstriction syndrome may be confused with preeclampsia/eclampsia, is characterized by reversible multifocal arterial narrowing with thunderclap headache and less commonly focal neurologic deficits, and treatment for PRES and reversible cerebral vasoconstriction syndrome "may include" medical control of hypertension, antiepileptic medication, and long-term neurologic follow-up.

---

### RCVSscore and diagnostic approach for reversible cerebral vasoconstriction syndrome [^e32d62a8]. Neurology (2019). Medium credibility.

The clinical calculator "Reversible cerebral vasoconstriction syndrome score (RCVS₂ score)" for reversible cerebral vasoconstriction syndrome.

The Reversible Cerebral Vasoconstriction Syndrome Score, abbreviated as RCVS₂ score, is a clinical calculator used in the field of neurology. It is specifically designed for patients suspected of having reversible cerebral vasoconstriction syndrome (RCVS), a condition characterized by a group of disorders featuring reversible narrowing of the cerebral arteries.

The RCVS₂ score is used to predict the likelihood of a patient having RCVS. It takes into account various factors such as the patient's age, sex, presence of thunderclap headache, and the absence of aneurysm on neuroimaging. The score ranges from 0 to 10, with higher scores indicating a higher probability of RCVS.

The clinical utility of the RCVS₂ score is to aid in the early diagnosis of RCVS, which can be challenging due to its diverse clinical presentations and the lack of specific diagnostic tests. Early diagnosis can lead to appropriate management and prevention of potential complications such as stroke.

There are no specific exclusion criteria for the use of the RCVS₂ score. However, it should be noted that this score is not definitive and should be used in conjunction with other clinical findings and diagnostic tests. It may not be as accurate in patients with other co

The Reversible Cerebral Vasoconstriction Syndrome Score (RCVS₂) calculator assesses five clinical factors to predict RCVS likelihood. Each factor is assigned a score, and their sum determines the risk interpretation.

The scoring system per factor is as follows:

1. **Recurrent or single thunderclap headache**:
- Absent = 0
- Present = 5

2. **Intracranial carotid artery involvement**:
- Not affected = 0
- Affected = 2

3. **Vasoconstrictive trigger**:
- Present = 3
- Absent = 0

4. **Sex**:
- Male = 0
- Female = 1

5. **Subarachnoid hemorrhage on imaging**:
- Absent = 0
- Present = 1

To compute the RCVS₂ score, collect input responses for each factor, translate them into numerical values using the predefined scale, and sum them up to get the total score. The interpretation is based on the total score as follows:

- A score of 2 or less indicates a negative RCVS diagnosis.
- A score between 3 and 4 indicates an equivocal RCVS diagnosis.
- A score of 5 or more indicates a positive RCVS diagnosis.

---

### RCVS: by clinicians for clinicians-a narrative review [^e08dcb7d]. Journal of Neurology (2023). Medium credibility.

Introduction

Reversible cerebral vasoconstriction syndrome (RCVS), whose cardinal symptom is acute, worst-ever headache (thunderclap headache (TCH)) in approximately 85% of cases, is mainly a clinical–radiological syndrome and may or may not include neurological deficits. The clinical presentation often depends on complications such as ischemic stroke, intracranial hemorrhage, and posterior reversible encephalopathy syndrome. Depending on the affected area, aphasia, hemiparesis, hemianopsia, epileptic seizures, or Balint syndrome may occur in up to 43% of cases. In > 85% of cases, a characteristic episode of TCH can be seen approximately 2–3 weeks prior. Cranial imaging by computed tomography (CT) or magnetic resonance imaging (MRI) should be followed by vascular imaging with CT angiography or MR angiography. Aside from the treatment of acute complications, such as stroke, intracranial hemorrhage, and epileptic seizures, the first-line drug for RCVS treatment is the calcium channel antagonist nimodipine. It is administered first orally and then intra-arterially in fulminant cases. In 2007, Calabrese et al. characterized RCVS, for which there already existed multiple case reports and different terms (Table 1). A detailed overview of RCVS cases characterized by risk factors/triggers and complications can be found in the "Supplementary Information" section (see Online Reference 1). Diagnostic criteria have also been established (Table 2). RCVS is mainly marked by widespread vasoconstriction from distal to proximal vascular segments, which regresses within 3 months and is mainly precipitated by various factors, such as vasoactive drug intake or postpartum status. The pathophysiology of this syndrome is still not fully understood, but it is thought to encompass two main mechanisms: endothelial dysfunction and disturbances in cerebral vascular tone caused primarily by sympathetic overactivation.

Table 1
Different former terms for RCVS

Table 2
The main diagnostic criteria of RCVS, established by Calabrese et al. 2007

The aim of this narrative review is to link the precipitating factors, pathophysiology and complications of RCVS. Another important point is the detailed analysis of possible differential diagnoses to prevent misdiagnosis and protect patients from unnecessary, risky diagnostics, and even harmful therapy.

---

### Clinical associations and causes of convexity subarachnoid hemorrhage [^0cded3fd]. Stroke (2014). Low credibility.

Background and Purpose

It has been previously found noted that ≈15% to 20% of subarachnoid hemorrhage (SAH) is nonaneurysmal. Nontraumatic convexity SAH (cSAH) is increasingly recognized. Data concerning incidence and associations are scant.

Methods

We identified all SAH-coded cases from South Australian public hospitals between January 2005 and July 2011. Electronic discharge summaries were reviewed, and cases of cSAH were ascertained. Clinical and radiological features were recorded, and pathogenesis was assigned.

Results

Of 742 cases with SAH, 41 (6%) cases were cSAH, giving a minimum population annual incidence of 5.1 per million (95% confidence interval, 3.7–7.0). Median age was 70 years (interquartile range, 48–79). Commonest causes were cerebral amyloid angiopathy (39%), reversible cerebral vasoconstriction syndrome (17%), cerebral venous sinus thrombosis (10%), large-vessel stenotic atherosclerosis (10%), and posterior reversible encephalopathy syndrome (5%). No cause was identified in 20% (mostly elderly patients with incomplete evaluation). Most (63%) presented with transient neurological symptoms. Many (49%) were misdiagnosed as transient ischemic attacks and treated inappropriately with antithrombotics.

Conclusions

cSAH comprises a significant proportion of SAH. Commonest causes are cerebral amyloid angiopathy in the elderly and reversible cerebral vasoconstriction syndrome in the young, but differential diagnosis is broad. Misdiagnosis is common and leads to potentially harmful treatments.

---

### Retrospective analysis of 80 patients diagnosed with reversible cerebral vasoconstriction syndrome in the helsinki metropolitan area [^b62c2190]. European Journal of Neurology (2025). Medium credibility.

Our study benefits from using the only hospital in the Helsinki Metropolitan Area offering specialized neurological treatment. With a dedicated neurological ED led by neurologists, high‐quality care and expertise are ensured in diagnosing conditions like RCVS. Moreover, our standard practice of conducting imaging studies, including angiography, for all patients admitted with TCH provides comprehensive data for analysis, which improves the reliability of our findings.

---

### Reversible cerebral vasoconstriction syndrome in pediatrics: a case series and review [^a8e0fb06]. Journal of Child Neurology (2017). Low credibility.

Reversible cerebral vasoconstriction syndrome is a transient vasculopathy associated with severe headaches and stroke. In most cases of reversible cerebral vasoconstriction syndrome, there is a precipitating event or trigger, such as pregnancy, serotonin agonist treatment or illicit drug use. The authors present 2 pediatric cases of reversible cerebral vasoconstriction syndrome and review the previous 11 pediatric cases in the literature. In many instances, the clinical and radiographic features are similar in both pediatric and adult cases. In the pediatric group, reported potential triggers include trauma (1/13), exercise (2/13), water to the face (3/13), hypertension (3/13), and medication or substance use (4/13). One surprising difference is that 11 out of 13 pediatric patients with reversible cerebral vasoconstriction syndrome are male while most cases in adults are female. Many of the pediatric patients with reversible cerebral vasoconstriction syndrome were treated with a calcium channel blocker and the overall outcome of pediatric reversible cerebral vasoconstriction syndrome was good, with most patients experiencing a full recovery.

---

### Blood-brain barrier breakdown in reversible cerebral vasoconstriction syndrome: implications for pathophysiology and diagnosis [^88b22aa1]. Annals of Neurology (2017). Low credibility.

Objective

Diagnosis of reversible cerebral vasoconstriction syndrome (RCVS) is currently based on luminographic findings of vasoconstriction. In addition to vasoconstriction, the blood-brain barrier (BBB) breakdown has been postulated as a central mechanism of RCVS. Our aim was to document BBB breakdown in patients with RCVS and its role for the pathophysiology-based diagnosis of RCVS.

Methods

We prospectively recruited 72 consecutive patients with thunderclap headache who did not have aneurysmal subarachnoid hemorrhage from April 2015 to July 2016 at the Samsung Medical Center. Based on the International Classification of Headache Disorders-3 beta criteria and neuroimaging, patients were classified as having RCVS (n = 41; "definite" in 29 imaging-proven patients and "probable" in 12 imaging-negative patients), other secondary causes (n = 7), and thunderclap headache of undetermined cause (n = 24). BBB breakdown was evaluated using contrast-enhanced fluid-attenuated inversion recovery magnetic resonance imaging.

Results

BBB breakdown was documented in 20 (69.0%) patients with definite RCVS, 3 (25.0%) patients with probable RCVS, and none with other secondary causes. BBB breakdown was present in RCVS patients with (n = 4) and without (n = 19) concomitant posterior reversible encephalopathy syndrome. In patients with RCVS, the extent of BBB breakdown was independently associated with neurological complications (multivariate odds ratio = 1.48 per 1 territorial increase, 95% confidence interval = 1.04–2.12, adjusted p = 0.032). Three (12.5%) patients with thunderclap headache of undetermined cause were newly classified as having RCVS by the presence of BBB breakdown.

Interpretation

This is the first study to show BBB breakdown in patients with RCVS. This finding might broaden our understanding of the pathophysiology and clinical spectrum of RCVS. Ann Neurol 2017;81:454–466.

---

### Retrospective analysis of 80 patients diagnosed with reversible cerebral vasoconstriction syndrome in the helsinki metropolitan area [^ca3e10dd]. European Journal of Neurology (2025). Medium credibility.

The primary outcome measure was rate of complications during the disease course. The secondary outcome measure was clinical outcome at 3 months as assessed by the modified Rankin Scale (mRS). mRS assessment was performed retrospectively based on patient medical records.

Ischaemic stroke, ICH, SAH and transient ischaemic attack (TIA) diagnoses were based on American Heart Association/American Stroke Association (AHA/ASA) definitions. According to the AHA/ASA, CNS infarction is brain, spinal cord or retinal cell death attributable to ischaemia based on (1) pathological, imaging or other objective evidence of cerebral, spinal cord or retinal focal ischaemic injury in a defined vascular distribution or (2) clinical evidence of cerebral, spinal cord or retinal focal ischaemic injury based on symptoms persisting ≥ 24 h or until death and other aetiology excluded. TIA is defined as focal arterial ischaemia with transient symptoms lasting < 24 h and without evidence of infarction by pathology or images. ICH is defined as a focal collection of blood within the brain parenchyma or ventricular system that is not due to trauma, including parenchymal haemorrhage after CNS infarction. Based on AHA/ASA definitions, SAH is a bleeding into the subarachnoid space. No case of aneurysmatic SAH was found in this cohort based on vascular imaging and cerebrospinal fluid investigations.

Posterior reversible leukoencephalopathy syndrome was diagnosed by suitable clinical picture and characteristic MRI findings, including focal or confluent areas of increased signal on T2‐weighted and fluid‐attenuated inversion recovery images. Headache attributed to RCVS was diagnosed according to the diagnostic criteria of the latest International Classification of Headaches (ICHD‐3). Secondary TCH was defined as a severe head pain with abrupt onset, reaching maximum intensity in less than 1 min, lasting at least 5 min, and not better accounted for by another ICHD‐3 diagnosis. The numerical rating scale from 0 (no pain) to 10 (worst pain ever experienced) is used routinely in our hospital for patient assessment.

'Non‐smoker' describes a person who has never smoked regularly; 'ex‐smoker' describes a person who previously smoked regularly but stopped > 6 months before symptom onset. 'Smoker' describes a person who smoked regularly during symptom onset or discontinued smoking < 6 months before symptom onset.

---

### Cerebral infarctions following an increase in corticosteroids: an atypical case of reversible cerebral vasoconstriction syndrome [^8c3c31b4]. Journal of Neurology (2022). Medium credibility.

Dear Editors,

The causes of reversible cerebral vasoconstriction syndrome (RCVS) are manifold. Among the most common are the use of certain vasoactive drugs such as antidepressants, nasal decongestants, triptans and immunosuppressants (tacrolimus, cyclophosphamide) as well as illicit drugs (cannabis, amphetamines, ecstasy and cocaine), postpartum period, traumatic brain injury, catecholamine-producing tumors and vascular association (cervical artery dissection and carotid endarterectomy). Middle-aged women are most often affected. In 82–100% of cases, the first symptom is thunderclap headache (TCH). Common complications are ischemic stroke (39%), cortical subarachnoid hemorrhage (cSAH) (34%), intracerebral hemorrhage (ICH) (20%) and brain vasogenic edema consistent with posterior reversible encephalopathy syndrome (PRES) (38%). Often, ischemic strokes due to RCVS are located in border zones and bilaterally. These consequences usually occur about 2 weeks after the TCH-episode. The pathophysiology behind RCVS is poorly understood and multifactorial. It is thought to be due to an aberrant sympathetic response of vascular tone regulation starting distally and moving proximally. One possible reason for the time lag between hyper-acute, worst-ever headache and stroke is the direction of vasoconstriction from small to large vessels.

---

### Frequency of ischaemic stroke and intracranial haemorrhage in patients with reversible cerebral vasoconstriction syndrome (RCVS) and posterior reversible encephalopathy syndrome (PRES) – A systematic review [^346a28c9]. European Journal of Neurology (2024). Medium credibility.

Frequency of ischaemic stroke and intracranial haemorrhage in patients with

In total, we included 14 studies in patients with RCVS: 11 of which reported on unselected RCVS patients; and three studies which only included patients suffering from coronavirus disease, with intracranial haemorrhage, and any complications, respectively. The 11 studies, which included all RCVS patients, provide reports on 2746 patients. Of these, 487 (15.9%, 95% CI 9.6%–23.4%) had suffered an ischaemic stroke, and 181 of 705 (22.1%, 95% CI 10%–39.6%) had an intracranial haemorrhage (Figures 2 and 3). In total, 813 (20.3%, 95% CI 11.2%–31.2%) patients suffered from SAH and 274 of 2725 (6.7%, 95% CI 3.6%–10.7%) suffered from IPH (Figures S1 and S2). For ischaemic stroke, the outcome varies from 1.5% to 55.6%. For intracranial haemorrhage, a variation of 3.1%–63.3% was found.

FIGURE 2
Frequency of ischaemic stroke in patients with reversible cerebral vasoconstriction syndrome (FIGURE 3
Frequency of intracranial haemorrhage in patients with reversible cerebral vasoconstriction syndrome (

---

### A woman with the worst headache of her life | NEJM resident 360… [^15373e28]. resident360.nejm.org (2024). Medium credibility.

Literature Clinical Pearls & Morning Reports Published June 12, 2024 The most important "cannot miss" cause of thunderclap headache is aneurysmal subarachnoid hemorrhage, a medical emergency associated with high morbidity and mortality without timely treatment. Read the NEJM Case Records of the Massachusetts General Hospital here. Clinical Pearls Q: Name other causes of thunderclap headache, including those associated with convexal subarachnoid hemorrhage. A: Subarachnoid hemorrhage from a ruptured cerebral aneurysm almost never causes convexal subarachnoid hemorrhage. Arterial dissection is an uncommon cause of thunderclap headache; it can also cause convexal subarachnoid hemorrhage. Convexal subarachnoid hemorrhage due to arterial dissection is reported primarily in postpartum persons.

Posterior reversible encephalopathy syndrome is another uncommon cause of thunderclap headache that can also cause convexal subarachnoid hemorrhage. Thunderclap headache is a presenting symptom in 15% of patients with cerebral venous sinus thrombosis. Q: What is reversible cerebral vasoconstriction syndrome. A: RCVS is characterized by fluctuating and reversible narrowing of the intracranial arteries and occurs more commonly in women than in men. The mean age of patients with RCVS in cohort studies has ranged from 42 to 51 years, but children can also be affected. Patients in whom RCVS has been diagnosed typically report multiple thunderclap headaches that occur over a period of a few days to weeks. There is usually an emotional, physical, medical, or pharmacologic trigger. In addition, roughly 35% of patients with RCVS have convexal subarachnoid hemorrhage.

In fact, among patients without head trauma, RCVS is one of the most common causes of convexal subarachnoid hemorrhage. A: Imaging abnormalities include convexal subarachnoid hemorrhage, intracerebral hemorrhage, ischemic strokes in arterial watershed areas, and reversible brain edema. Hemorrhagic lesions occur earlier in the clinical course than ischemic lesions and are attributed to dynamic, centripetally progressing vasoconstriction and vasodilatation, which results in ischemia–reperfusion injury. Infarctions result from reduced cerebral perfusion. Self-limited generalized tonic–clonic seizures develop in up to 20% of patients with RCVS, and neurologic deficits such as cortical vision loss, encephalopathy, aphasia, hemiparesis, and ataxia develop in up to two thirds of affected patients. Despite these clinical and imaging abnormalities, outcomes are excellent, with 90 to 95% of patients with RCVS having complete recovery or only mild disability by the time of hospital discharge.

A: Treatment of headache with analgesic agents or even opioids is warranted. It is important to avoid exposure to triggers, as well as physical exertion, until recurrent thunderclap headaches subside — usually over a period of days to weeks. The Valsalva maneuver can exacerbate thunderclap headache, so stool softeners may be recommended. Calcium-channel blockers or intravenous magnesium are often administered to counter vasoconstriction, although evidence of their effectiveness is lacking. Intraarterial vasodilator therapy should be administered only in patients with a clearly progressive clinical course, as this invasive procedure carries the risk of reperfusion injury, which can be fatal.

---

### Multimodal imaging of reversible cerebral vasoconstriction syndrome: a series of 6 cases [^01407823]. AJNR: American Journal of Neuroradiology (2012). Low credibility.

RCVS is a clinical condition of recurrent severe headaches that may be associated with ischemic or hemorrhagic stroke and that is defined by the presence of segmental vasoconstriction in multiple cerebral arteries. The angiographic appearance resembles vasculitis, except that the abnormalities resolve during the course of several months. Because the treatment of RCVS differs from that for vasculitis, radiologists must understand the clinical and radiologic features so as to better guide imaging algorithms and facilitate diagnosis. We present a series of 6 cases of RCVS that highlight the imaging features across multiple modalities.

---

### Headaches in pregnancy and postpartum: ACOG clinical practice guideline no. 3 [^48c9b815]. Obstetrics and Gynecology (2022). High credibility.

Reversible cerebral vasoconstriction syndrome (RCVS) and posterior reversible encephalopathy syndrome (PRES) — Reversible cerebral vasoconstriction syndrome is characterized by severe headaches and diffuse segmental constriction of the cerebral arteries that resolves spontaneously within a few months, and there is an overlapping pathophysiology between RCVS and PRES. Key features of RCVS include fluctuating and sudden headaches, transient blindness and confusion, and rapid improvement in the postpartum period. A large percentage of patients have no abnormalities on initial CT or MRI, but repeat imaging demonstrates lesions over a few days, and abnormal cerebral angiography is the primary diagnostic feature of RCVS, which can be documented with computed tomography angiogram or magnetic resonance angiogram. In PRES, the headache is likely due to cerebral edema in the setting of failure of autoregulation of the cerebral vasculature.

---

### Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors [^24641c44]. Stroke (2010). Low credibility.

Background and Purpose

Reversible cerebral vasoconstriction syndrome (RCVS), characterized by severe headaches and reversible constriction of cerebral arteries, may be associated with ischemic and hemorrhagic strokes. The aim of this study was to describe the frequency, patterns, and risk factors of intracranial hemorrhages in RCVS.

Methods

We analyzed prospective data on 89 consecutive patients with RCVS, of which 8 were postpartum and 46 used vasoactive substances. Standard bivariate and multivariate statistical tests were applied to compare patients with and without hemorrhage.

Results

Thirty patients (34%), of which 5 were postpartum and 12 used vasoactive substances, developed at least 1 type of intracranial hemorrhage, including cortical subarachnoid (n = 27), intracerebral (n = 11), and subdural hemorrhage (n = 2). Patients with hemorrhage had an older age (46.6 versus 41.6 years, P = 0.049) and were more frequently females (90% versus 51%, P = 0.0017) or were migrainers (43% versus 19%, P = 0.022) than those without hemorrhage. Multivariate testing identified 2 independent risk factors of hemorrhage in RCVS: female gender (OR, 4.05; 95% CI, 1.46 to 11.2) and migraine (OR, 2.34; 95% CI, 1.06 to 5.18). Patients with hemorrhage had a greater risk of persistent focal deficits (30% versus 2%, P = 0.0002), cerebral infarction (13% versus 2%, P = 0.039), posterior reversible encephalopathy syndrome (17% versus 3%, P = 0.041) at the acute stage, and of inability to resume normal activities at 6 months (27% versus 0%, P < 0.0001).

Conclusions

In RCVS, women and migrainers seem to be at higher risk of intracranial hemorrhage. Overall, intracranial hemorrhages are frequent in RCVS and are associated with a more severe clinical spectrum.

---

### Reversible cerebral vasoconstriction syndrome during caesarean section [^b8726482]. BMJ Case Reports (2019). High credibility.

We describe the case of a 25-year-old parturient who presented sudden onset and short-lived severe headache caused by reversible cerebral vasoconstriction syndrome (RCVS) during an emergency caesarean section. The syndrome was triggered by phenylephrine administered intravenously to correct arterial hypotension following spinal anaesthesia. RCVS is a clinical and radiological syndrome attributed to transient disturbance in the control of cerebral arterial tone resulting in vasospasms. The syndrome can be precipitated by several triggers, including vasoactive drugs, often used during spinal anaesthesia, illicit drugs, pregnancy and postpartum state. Diagnosis and management can be challenging during pregnancy, peripartum or post partum, since many medications commonly used during these periods must be avoided to prevent triggering RCVS. The aim of this report is to raise the awareness, particularly for anaesthesiologists and obstetricians, of this rare and potentially serious syndrome. We discuss diagnosis, triggers, pathogenesis, clinical course and complications, as well as coordinated multidisciplinary management plans.

---

### Grief-induced reversible cerebral vasoconstriction syndrome (RCVS) [^b921640a]. BMJ Case Reports (2020). High credibility.

I was glad to be a neurology/neurosurgery Grand Rounds patient at the 30 March 2017 Grand Rounds presentation. Having this article published also will hopefully help others dealing with RCVS. Having my life saved has inspired me to want to help others. There are really no words to describe the extent of my gratitude for surviving such a dangerous life-death situation.

Learning points

Reversible cerebral vasoconstriction syndrome (RCVS) is a group of conditions characterised by reversible constriction of cerebral arteries.
Most patients present with a thunderclap headache.
Approximately one-third of patients develop ischaemic or haemorrhagic strokes or reversible brain oedema on neuroimaging.
Emotional stress and grief, based on our case could be a potential trigger for RCVS.

---

### Frequency of ischaemic stroke and intracranial haemorrhage in patients with reversible cerebral vasoconstriction syndrome (RCVS) and posterior reversible encephalopathy syndrome (PRES) – A systematic review [^67e89b43]. European Journal of Neurology (2024). Medium credibility.

RESULTS

Literature search

Our searches returned 848 and 867 results, respectively (Figure 1). Following the selection of titles and abstracts, 760 and 777 articles were excluded as unsuitable for the review. In the case of the remaining 90 articles, the full text was read, and 10 studies were excluded since they had investigated only paediatric patients. A further 13 articles were excluded due to missing imaging details regarding haemorrhage or ischaemia. In addition, seven articles were excluded based on being a case report. Furthermore, seven studies were excluded due to duplicate publications and five studies due to not being available in the English language. Ultimately, 48 articles were included: 34 concerning PRES and 14 concerning RCVS (Tables 1 and 2).

FIGURE 1
Literature search. PRES, posterior reversible encephalopathy syndrome; RCVS, reversible cerebral vasoconstriction syndrome.

TABLE 1
Overview of studies relating to reversible cerebral vasoconstriction syndrome (RCVS) – frequency of intracranial haemorrhage and ischaemic stroke.

TABLE 2
Overview of studies relating to posterior reversible encephalopathy syndrome (PRES) – frequency of intracranial haemorrhage and ischaemic stroke.

---

### Complications of reversible cerebral vasoconstriction syndrome in relation to age [^ed18e2d9]. Journal of Neurology (2023). Medium credibility.

The overall clinical outcome at 3 months of follow-up in our cohort was very good with an mRS score 0–1 in 96.5% of patients. Contrarily, an analysis of the US Nationwide Inpatient Database including 2020 patients with RCVS found a poor early outcome of discharge to another facility after hospitalisation or in-hospital death in one third of patients. This discrepancy might be explained mainly by different recruitment patterns. While the US study described a population of hospitalised patients, two third of our patients were recruited from an emergency headache center, and one third of our patients were treated on an outpatient basis. While the emergency headache center is easily accessible for any patient with a headache, capacities of our neurovascular units are restricted, thus limiting the transfer of severely affected patients from other hospitals or departments. This might have contributed to a selection bias for milder forms in our cohort with underestimation of the outcome severity. On the other hand, pure and mild cephalagic forms of RCVS might also be underrepresented, since those patients might not consult or might not return for 3 months follow-up, rendering impossible the definite diagnosis of RCVS. Overall, recruitment from two neurological wards and one emergency headache center might have balanced selection bias for milder cephalalgic vs more severe forms, respectively.

In our cohort, predictors for an unfavourable functional outcome included the use of serotonergic antidepressants prior to RCVS onset, and the occurrence of IS or ICH during RCVS. Only the use of serotonergic antidepressants and the occurrence of ICH were independent predictors. Prior studies have identified IS as the most consistent predictor, and ICH as another independent predictor for a poor functional outcome, underlining the importance of careful monitoring and rehabilitative measures in patients with these types of lesions. Concerning serotonergic antidepressants, prior studies have found an association with clinical and angiographic worsening but not poor outcome (defined as mRS > 3). Taken together, these findings suggest that patients with use of serotonergic antidepressants might benefit from in-hospital care allowing for close monitoring.

Contrarily to two prior studies, we did not find an association of advanced age and an unfavourable outcome. In our cohort, patients aged > 50 years were significantly more often hospitalised. The in-patient stay might have allowed for a prevention of clinical worsening, e.g. by the means of blood pressure management and physical rest.

---

### Short-term effects of air pollution and weather on reversible cerebral vasoconstriction syndrome: a retrospective bicenter study [^d1c47aab]. Journal of Neurology (2025). Medium credibility.

Background

Reversible cerebral vasoconstriction syndrome (RCVS) is characterized by thunderclap headaches and transient cerebral vasoconstriction. The influence of environmental factors, particularly air pollution and weather conditions, on RCVS remains poorly understood.

Methods

From 2010 to 2022, clinical data from two hospitals were analyzed alongside air pollution and meteorological data provided by Air Pays de la Loire and Météo-France. A time-stratified case-crossover design was used to evaluate the association between RCVS onset and daily mean concentrations of O 3, PM 10, PM 2.5, and NO 2, using spatial modeling of residential exposure. Pollutant effects were examined over lag periods of up to three days, with adjustments for temperature and atmospheric pressure.

Results

A total of 216 patients were included (mean age: 39.9 years; SD: 12.3; sex ratio: 1:1). In the three days preceding RCVS onset, only PM 10 concentrations remained significantly higher compared to the day of onset (19.03 vs. 17.99 µg/m 3, P = 0.0029). A significant downward trend in PM 10 levels was observed over this period (slope -0.735, P = 0.0286), whereas no significant changes were found for PM 2.5, O 3, or NO 2. PM 10 was the only pollutant significantly associated with RCVS onset across lag days (Lag 0: OR 0.747, 95% CI: 0.579–0.962, P = 0.024; Lag 1: OR 0.770, 95% CI: 0.599–0.989, P = 0.041; Lag 2: OR 0.776, 95% CI: 0.604–0.997, P = 0.047; Lag 3: OR 0.768, 95% CI: 0.599–0.984, P = 0.037). After adjusting for atmospheric pressure and temperature, these associations were no longer statistically significant.

Conclusion

This study suggests a short-term decrease in PM 10 levels prior to RCVS onset and a negative association between PM₁₀ concentration and occurrence. These findings contribute to understanding the potential environmental triggers of RCVS in the context of changing air quality and climate.

---

### Differentiating RCVS with SAH… [^a00fc9eb]. JAMA Network (2013). Excellent credibility.

© 2025 Importance Reversible cerebral vasoconstriction syndrome is a clinical-angiographic syndrome characterized by recurrent thunderclap headaches and reversible segmental multifocal cerebral artery narrowing. More than 30% of patients with RCVS develop subarachnoid hemorrhage. Patients with RCVS with SAH are often misdiagnosed as having potentially ominous conditions such as aneurysmal SAH or cryptogenic "angiogram-negative" SAH owing to overlapping clinical and imaging features. Results Predictors differentiating RCVS-SAH from aSAH were younger age, chronic headache disorder, prior depression, prior chronic obstructive pulmonary disease, lower Hunt-Hess grade, lower Fisher SAH group, higher number of affected arteries, and the presence of bilateral arterial narrowing.

Predictors differentiating RCVS-SAH from cSAH were younger age, female sex, prior hypertension, chronic headache disorder, lower Hunt-Hess grade, lower Fisher SAH group, and the presence of bilateral arterial narrowing. Quiz Ref IDRecent studies have characterized the reversible cerebral vasoconstriction syndrome as a clinical-angiographic syndrome typically heralded by acute, severe "thunderclap" headaches associated with reversible segmental multifocal cerebral artery vasoconstriction. 1–5 Approximately one-third of patients develop ischemic stroke, lobar hemorrhage, or convexal subarachnoid hemorrhage. All patients with RCVS-SAH underwent 2 angiographic studies, except for 1 patient who only underwent DSA. The presence of arterial narrowing was assessed, in order of preference, by DSA, CTA, MRA, or transcranial Doppler ultrasonographic study.

The degree of arterial narrowing was graded as 0, 1, or 2 based on visual inspection of angiographic studies or using standard transcranial Doppler ultrasonographic study criteria. 17 If multiple arteries were affected, the most severe grade of arterial narrowing was selected. The laterality and number of vessels involved were recorded. The time to vasoconstriction was measured in days after onset of first TCH. All admission and follow-up brain imaging studies were reviewed for the presence of infarction or edema. Baseline clinical characteristics are shown in Table 1. Patients with RCVS-SAH were predominantly women and, on average, 12 years younger than the patients with aSAH and 11 years younger than the patients with cSAH.

Compared with both aSAH and cSAH cohorts, more patients with RCVS-SAH had a history of chronic headache disorder, depression/anxiety, chronic obstructive pulmonary disease, and illicit drug and alcohol use. By definition, all patients with RCVS-SAH developed cerebral arterial narrowing. In comparison, cerebral vasospasm developed in 62% of patients with aSAH and in 29% of patients with cSAH at the median time points of day 6 and day 7 after SAH, respectively. The RCVS-SAH group showed more severe cerebral artery narrowing and more commonly had multiple-artery involvement and bilateral abnormalities compared with the aSAH and cSAH groups. Quiz Ref IDMultivariable logistic regression modeling of baseline epidemiological variables, adjusting for prior antidepressant use, showed that younger age, chronic headache disorder, history of depression/anxiety, and COPD were independent predictors of RCVS-SAH.

---

### Type of headache at onset and risk for complications in reversible cerebral vasoconstriction syndrome [^320ac962]. European Journal of Neurology (2022). Medium credibility.

Background

In a recent Italian study, 30% of patients with reversible cerebral vasoconstriction syndrome (RCVS) presented without thunderclap headache (TCH), and tended to present more severe forms of RCVS than patients with TCH. We aimed to analyze the risk for complications of RCVS in patients with and without TCH at onset.

Methods

In a pooled cohort of 345 French patients with RCVS, we compared patients with and without TCH at onset regarding rates of neurological complications, and the functional outcome at 3 months.

Results

As compared to the 281 patients with TCH at onset, the 64 patients without TCH had a higher risk for any neurological complication (61% vs. 24%, OR 4.9, 95% CI 2.8–8.7, p < 0.001). The association was strongest for cervical artery dissections (28% vs. 5%, OR 8.1, 95% CI 3.7–17.6, p < 0.001), followed by posterior reversible encephalopathy syndrome (17% vs. 3%, OR 7.1, 95% CI 2.7–18.4, p < 0.001), seizures (9% vs. 2.5%, OR 4.1, 95% CI 1.3–12.5, p = 0.019), and subarachnoid hemorrhage (41% vs. 16%, OR 3.5, 95% CI 1.9–6.3, p < 0.001). In multivariable analysis, the risk for any neurological complication remained significantly elevated in the absence of TCH (OR 3.5, 95% CI 1.8–6.8, p < 0.001). The functional outcome was equal in both groups, with a modified Rankin scale score of 0–1 in ≥ 90% of patients.

Conclusions

Absence of TCH at onset might predict a higher risk of complications in RCVS. Our results warrant further multicentric studies to prove this finding.

---

### Grief-induced reversible cerebral vasoconstriction syndrome (RCVS) [^0af2b7d5]. BMJ Case Reports (2020). High credibility.

Stress is under-recognised as a potential causative factor for reversible cerebral vasoconstriction syndrome (RCVS). Here we present a case of RCVS occurring during a time of extreme emotional duress. A 46-year-old female patient with medical history of bipolar disorder developed a severe headache during her father's funeral. The following day she was discovered to have bilateral hemiparesis, aphasia, encephalopathy and was brought emergently to the hospital. Neuroimaging revealed a 33 mL left fronto-parietal haematoma with subarachnoid blood near the vertex bilaterally. She underwent craniotomy, haematoma evacuation and external ventricular drain placement. The patient received two cerebral angiograms, the first showing multifocal cerebral vasoconstriction and the second showing resolution of these changes. She improved significantly over the course of her 3-week hospitalisation and eventually made a full recovery, including the ability to speak fluently in six languages with no significant deficits other than hypersomnia; she now requires 10 hours of sleep each night as compared with 7 hours prior to her brain injury.

---

### Differentiating reversible cerebral vasoconstriction syndrome with subarachnoid hemorrhage from other causes of subarachnoid hemorrhage [^0f580512]. JAMA Neurology (2013). Medium credibility.

Importance

Reversible cerebral vasoconstriction syndrome (RCVS) is a clinical-angiographic syndrome characterized by recurrent thunderclap headaches and reversible segmental multifocal cerebral artery narrowing. More than 30% of patients with RCVS develop subarachnoid hemorrhage (SAH). Patients with RCVS with SAH (RCVS-SAH) are often misdiagnosed as having potentially ominous conditions such as aneurysmal SAH (aSAH) or cryptogenic "angiogram-negative" SAH (cSAH) owing to overlapping clinical and imaging features.

Objective

To identify predictors that can distinguish RCVS-SAH from aSAH and cSAH at the time of clinical presentation.

Design

Retrospective analysis of 3 patient cohorts: patients with RCVS (1998–2009), patients with aSAH (1995–2003), and patients with cSAH (1995–2003).

Setting

Academic hospital and tertiary referral center.

Participants

Consecutive patients with RCVS-SAH (n = 38), aSAH (n = 515), or cSAH (n = 93) whose conditions were diagnosed using standard criteria.

Main Outcomes and Measures

Multivariate logistic regression analysis was used to identify predictors that differentiate RCVS-SAH from aSAH and cSAH.

Results

Predictors differentiating RCVS-SAH from aSAH were younger age, chronic headache disorder, prior depression, prior chronic obstructive pulmonary disease, lower Hunt-Hess grade, lower Fisher SAH group, higher number of affected arteries, and the presence of bilateral arterial narrowing. Predictors differentiating RCVS-SAH from cSAH were younger age, female sex, prior hypertension, chronic headache disorder, lower Hunt-Hess grade, lower Fisher SAH group, and the presence of bilateral arterial narrowing.

Conclusions and Relevance

We identified important clinical and imaging differences between RCVS-SAH, aSAH, and cSAH that may be useful for improving diagnostic accuracy, clinical management, and resource utilization.

---

### Frequency of ischaemic stroke and intracranial haemorrhage in patients with reversible cerebral vasoconstriction syndrome (RCVS) and posterior reversible encephalopathy syndrome (PRES) – A systematic review [^7eca1bf3]. European Journal of Neurology (2024). Medium credibility.

Abstract

Background

Posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) may cause ischaemic stroke and intracranial haemorrhage. The aim of our study was to assess the frequency of the afore‐mentioned outcomes.

Methods

We performed a PROSPERO‐registered (CRD42022355704) systematic review and meta‐analysis accessing PubMed until 7 November 2022. The inclusion criteria were: (1) original publication, (2) adult patients (≥ 18 years), (3) enrolling patients with PRES and/or RCVS, (4) English language and (5) outcome information. Outcomes were frequency of (1) ischaemic stroke and (2) intracranial haemorrhage, divided into subarachnoid haemorrhage (SAH) and intraparenchymal haemorrhage (IPH). The Cochrane Risk of Bias tool was used.

Results

We identified 848 studies and included 48 relevant studies after reviewing titles, abstracts and full text. We found 11 studies on RCVS (unselected patients), reporting on 2746 patients. Among the patients analysed, 15.9% (95% CI 9.6%–23.4%) had ischaemic stroke and 22.1% (95% CI 10%–39.6%) had intracranial haemorrhage. A further 20.3% (95% CI 11.2%–31.2%) had SAH and 6.7% (95% CI 3.6%–10.7%) had IPH. Furthermore, we found 28 studies on PRES (unselected patients), reporting on 1385 patients. Among the patients analysed, 11.2% (95% CI 7.9%–15%) had ischaemic stroke and 16.1% (95% CI 12.3%–20.3%) had intracranial haemorrhage. Further, 7% (95% CI 4.7%–9.9%) had SAH and 9.7% (95% CI 5.4%–15%) had IPH.

Conclusions

Intracranial haemorrhage and ischaemic stroke are common outcomes in PRES and RCVS. The frequency reported in the individual studies varied considerably.

---

### Reversible cerebral vasoconstriction syndrome following indomethacin [^0a654559]. Cephalalgia (2014). Low credibility.

Background

Reversible cerebral vasoconstriction syndrome (RCVS) is characterized by severe thunderclap headaches and transient segmental cerebral arterial vasoconstriction. Precipitating factors, including the postpartum state and exposure to vasoactive substances are identified in approximately 50% of cases. Non-steroidal anti-inflammatory drugs have rarely been associated with RCVS.

Case Description

We report a case of a 51-year-old female with RCVS after administration of indomethacin given to relieve pain caused by renal colic. Cerebral imaging showed non-aneurysmal cortical subarachnoid hemorrhage, and formal angiography demonstrated widespread multifocal segmental narrowing of medium-sized cerebral arteries. These changes resolved on repeat angiography at 3 weeks.

Discussion

Indomethacin is a commonly used drug for treatment of certain primary headache disorders. To date, its mechanism of action remains unclear. A well described side effect of indomethacin is headache, which may be secondary to its vasoconstrictive effects. In our case, we postulate indomethacin, either alone or in combination with emotional stress from pain, triggered or exacerbated an underlying predisposition to RCVS.

---

### Cerebrospinal fluid findings in reversible cerebral vasoconstriction syndrome: a way to differentiate from cerebral vasculitis? [^2c672251]. Clinical and Experimental Immunology (2018). Low credibility.

Reversible cerebral vasoconstriction syndrome (RCVS) is characterized by an acute onset of severe headache and multi-focal segmental vasoconstriction of cerebral arteries resolving within 12 weeks. Diagnostic criteria include normal or near-normal findings in cerebrospinal fluid (CSF) analysis, especially leucocyte levels < 10/mm³. Distinguishing RCVS from primary angiitis of the central nervous system (PACNS) is essential to avoid unnecessary and sometimes unfavourable immunosuppressive treatment. We reviewed retrospectively the clinical and diagnostic data of 10 RCVS patients who presented in our neurological department from 1 January 2013 to February 2017. The main purpose was to verify whether CSF leucocyte counts < 10/mm³ serve to discriminate RCVS from PACNS. Five of six patients who underwent lumbar puncture presented with CSF leucocyte levels ≥ 10/mm³. Two patients had a history of misinterpretation of CSF pleocytosis as cerebral vasculitis and of immunosuppressive treatment. A complete restitution of cerebral vasoconstriction was evident in all. No patient had further cerebral strokes or bleedings without immunosuppressive treatment over more than 12 weeks. Despite the established diagnostic criteria, RCVS can manifest with CSF leucocyte levels > 10/mm³. Careful anamnesis and the response of 'vasculitis-like angiography' to nimodipine given as a test during angiography and as oral medication are key to differentiate RCVS from cerebral vasculitis.

---

### Postpartum angiopathy and other cerebral vasoconstriction syndromes [^72872ee0]. Neurocritical Care (2005). Low credibility.

The phenomenon of reversible cerebral arterial segmental vasoconstriction has been associated with several conditions including pregnancy and puerperium ("postpartum angiopathy"), thunderclap headache, and use of vasoconstrictive medications. Patients with cerebral vasoconstriction typically present with sudden, severe, and recurrent ("thunderclap") headaches and can develop strokes. Cerebral vasoconstriction syndromes are under- recognized, are poorly characterized, and are frequently misdiagnosed as primary cerebral vasculitis. This article presents an illustrative case report and reviews the historical aspects, clinical and imaging characteristics, etiology, differential diagnosis, management, and prognosis of cerebral vasoconstriction syndromes.

---

### Headaches in pregnancy and postpartum: ACOG clinical practice guideline no. 3 [^d0a89e62]. Obstetrics and Gynecology (2022). High credibility.

Preeclampsia-associated headache — differential diagnosis notes, "In the setting of preeclampsia and headache, it is important to consider alternative secondary etiologies (ie, reversible cerebral vasoconstriction syndrome [RCVS], posterior reversible encephalopathy syndrome [PRES], infection) if accompanied by altered level of consciousness, vomiting, or fever" (GOOD PRACTICE POINT).

---

### Reversible segmental cerebral vasoconstriction (call-fleming syndrome): are calcium channel inhibitors a potential treatment option? [^8b96a6f3]. Cephalalgia (2003). Low credibility.

The Call-Fleming syndrome is characterized by sudden onset of thunderclap-like headache and focal neurological deficits. The pathophysiological correlate is a reversible segmental cerebral vasoconstriction frequently associated with focal cerebral ischaemia. The syndrome has been described in a variety of clinical conditions, and recently an association between the syndrome and exposure to vasoactive drugs was observed. Effective treatment options are not known. A 63-year-old female developed sudden 'worst ever' headache. Initial neurological examination, laboratory blood tests, CSF examination and brain magnetic resonance imaging (MRI) were normal. Previous medical history was unremarkable and she did not take vasoactive drugs. Eleven days after the onset of headache she developed visual field impairment and a right-sided hemiparesis. Brain MRI revealed bilateral posterior and left parietal ischaemic strokes. Cerebral catheter angiography showed segmental arterial vasoconstriction. A vasodilative therapy with calcium channel inhibitors was started and serial transcranial Doppler ultrasonography demonstrated resolution of cerebral arterial vasoconstriction. The present case illustrates that calcium channel inhibitors may be an effective therapy for segmental cerebral arterial vasoconstriction. However, more clinical data are needed to prove this observation.

---

### Reversible cerebral vasoconstriction syndrome associated with hormone therapy for intrauterine insemination [^d1c8f035]. Cephalalgia (2010). Low credibility.

Introduction

Reversible cerebral vasoconstriction syndrome (RCVS) comprises a heterogeneous group of acute neurological diseases which are characterized by thunderclap headache and evidence of reversible multifocal constriction of cerebral arteries. A number of precipitating factors have been described in the literature, including recent childbirth and use of vasoactive substances.

Case Description

Here we present the case of a female patient with RCVS which occurred in the setting of hormonal ovarian stimulation for intrauterine insemination.

Discussion

This case possibly contributes to the understanding of the pathophysiological mechanisms underlying reversible cerebral vasoconstriction.

---

### Complications of reversible cerebral vasoconstriction syndrome in relation to age [^a053d7a5]. Journal of Neurology (2023). Medium credibility.

Materials and methods

Study design and selection criteria

This is a pooled analysis of one prospective and two retrospective RCVS cohorts, which have been recruited at the French University Hospitals of Paris Lariboisière and Montpellier, as described before.

We included patients ≥ 15 years old with confirmed RCVS meeting the following criteria: (1) unusual, recent, severe headaches of sudden or progressive onset with or without focal neurologic deficit and/or seizures; (2) cerebral vasoconstriction with at least 2 narrowing on 2 different arteries, assessed by noninvasive brain vascular imaging investigations (CTA, contrast-enhanced MRA or Time-of-Flight (TOF)-MRA) or conventional cerebral angiography; and (3) disappearance of arterial abnormalities within the first 3 months.

At both hospitals, the performance of cerebral (CT, MRI) and cerebrovascular imaging investigations (CTA, MRA or conventional cerebral angiography) was left to the discretion of the physician in charge of the patient. All patients received vascular imaging at least once at onset to confirm vasoconstriction as defined above (criterion 2), and once at 3 months follow-up to confirm reversibility of vasoconstriction (criterion 3). Parenchymal imaging was repeated in case of clinical worsening. MR sequences at both hospitals included at least DWI, ADC, FLAIR and T2✱ or SWI, respectively.

At Lariboisière Hospital, all consecutive patients with proven RCVS were prospectively included from 2004 to 2011 (cohort A, n = 173). 70% of the patients were recruited from the emergency headache center [EHC], and 30% from the neurologic department including a stroke unit. Patient characteristics, treatment, and assessment of reversibility of vasoconstriction have been previously described. All patients had a follow-up visit at 3 months in order to confirm clinical and radiological reversibility, and to assess the functional outcome. Further clinical follow-up visits were performed as previously described, with a mean follow-up period of 9.2 ± 3.3 years. After the end of the prospective study at Lariboisière Hospital, patients were retrospectively included from 2012 to 2015, following the same inclusion criteria (cohort B, n = 132). 80% of the patients were recruited from the EHC, and 20% from the neurology department.

---

### Reversible cerebral vasoconstriction syndrome induced by adrenaline [^2d644a12]. Cephalalgia (2012). Low credibility.

Introduction

Reversible cerebral vasoconstriction syndrome (RCVS) is characterized by acute severe thunderclap headaches and evidence of multifocal, segmental, reversible vasoconstrictions of the cerebral arteries. Several precipitating factors have been identified and reported, including the use of recreational substances or sympathomimetic drugs and the postpartum state.

Case Description

Here we present the case of a woman who developed RCVS after the administration of adrenaline (epinephrine) in the setting of an anaphylactic reaction during antibiotic allergy testing.

Discussion

To our knowledge, this is the first reported case of RCVS following the administration of exogenous adrenaline. This case contributes to the understanding of the physiopathological mechanisms underlying reversible cerebral vasoconstriction.

---

### Reversible cerebral vasoconstriction syndrome with posterior leucoencephalopathy after oral contraceptive pills [^7a59f1f1]. Cephalalgia (2010). Low credibility.

Reversible cerebral vasoconstriction syndrome (RCVS) is characterized by sudden-onset recurrent 'thunderclap' headaches with reversible multifocal narrowing of the cerebral arteries, often associated with focal neurological deficits from ischaemic or haemorrhagic stroke. It has been associated with exposure to vasoconstrictive drugs, pregnancy, migraine, and a variety of other conditions. Whereas the pathophysiology of RCVS remains unclear, changes in the levels of female hormones are considered important because RCVS predominantly affects women and is frequently associated with pregnancy. We report a patient with angiographically confirmed RCVS whose MRI showed reversible brain oedema, suggesting an overlap between RCVS and the reversible posterior leucoencephalopathy syndrome. The only identified risk factor was oral contraceptive pills started 1 month prior to onset, supporting a role for female reproductive hormones in precipitating this overlap syndrome.

---

### Idiopathic reversible cerebral vasoconstriction syndrome (RCVS) [^229d26cb]. BMJ Case Reports (2014). Medium credibility.

Reversible cerebral vasoconstriction syndrome is characterised by severe thunderclap headache with associated characteristic transient, multifocal, segmental vasoconstriction of cerebral arteries lasting several weeks to months. We describe a 50-years old woman who presented with a severe sudden onset occipital headache. Neuroimaging revealed segmental vasospasm affecting the intracerebral arteries. The pain improved gradually over the next 6weeks. Repeat brain MR angiography at 12weeks showed complete resolution of the segmental narrowing.

---

### Reversible cerebral vasoconstriction vs posterior reversible encephalopathy… [^2465c697]. JAMA Network (2016). Excellent credibility.

To the Editor We read with interest a recent Images in Neurology article, which presented an example of reversible cerebral vasoconstriction syndrome. 1 Sorensen1 described a woman who presented with tonic-clonic seizure following synthetic cannabis use, with improvement after 24 hours. The only presented images are T2-weighted sequences that demonstrate bilateral hyperintensities involving cortical and subcortical regions. Nabavizadeh SA, Vossough A. Reversible Cerebral Vasoconstriction Syndrome vs Posterior Reversible Encephalopathy Syndrome. JAMA Neurol. 2016;

---

### Gender and hormonal influences in reversible cerebral vasoconstriction syndrome [^ea13438e]. European Stroke Journal (2016). Low credibility.

Introduction

The reversible cerebral vasoconstriction syndromes, including postpartum angiopathy, have been characterized over the last decade. Women are predominantly affected. Some studies suggest that postpartum angiopathy carries a worse prognosis.

Patients and Methods

We compared the clinical, neuroimaging, and angiographic features of 36 men, 110 non-pregnant women and 16 postpartum women included in our single-center cohort of patients with reversible cerebral vasoconstriction syndromes encountered from 1998 to 2016.

Results

As compared to men, non-pregnant women were older (48 ± 11 vs. 34 ± 13 years, p < 0.001), had more underlying migraine (49% vs. 19%, p = 0.002), depression (53% vs. 14%, p < 0.001) and serotonergic antidepressant use (45% vs. 11%, p < 0.001), developed more clinical worsening (18% vs. 3%, p = 0.022), more infarcts (39% vs. 20%, p = 0.031) and worse angiographic severity scores (23 ± 14 vs. 10.9 ± 10.3, p < 0.001), but had similar discharge outcomes (modified Rankin scale scores 0–3, 90% vs. 91%, p = 0.768). Sexual activity was an important trigger in men (22% vs. 4%, p = 0.002). As compared to non-pregnant women, postpartum angiopathy patients were younger (33 ± 6 years, p < 0.001) and had less vasoconstrictive drug exposure (25% vs. 67%, p = 0.002) but showed similar clinical, radiological and angiographic findings and similar discharge outcomes (modified Rankin scale scores 0–3 in 94%, p = 0.633). There were no significant differences between pre- and post-menopausal women, or those with and without hysterectomy.

Discussion/Conclusion

The observed gender differences in reversible cerebral vasoconstriction syndromes may result from hormonal or non-hormonal factors. Hormonal imbalances may trigger reversible cerebral vasoconstriction syndromes. Given the absence of significant differences in the female subgroups, hormonal factors do not appear to significantly affect the course or outcome of reversible cerebral vasoconstriction syndromes.

---

### Atraumatic convexal subarachnoid hemorrhage: clinical presentation, imaging patterns, and etiologies [^dea9daff]. Neurology (2010). Low credibility.

Objective

To identify patterns of clinical presentation, imaging findings, and etiologies in a cohort of hospitalized patients with localized nontraumatic convexal subarachnoid hemorrhage.

Methods

Twenty-nine consecutive patients with atraumatic convexal subarachnoid hemorrhage were identified using International Classification of Diseases-9 code from 460 patients with subarachnoid hemorrhage evaluated at our institution over a course of 5 years. Retrospective review of patient medical records, neuroimaging studies, and follow-up data was performed.

Results

There were 16 women and 13 men between the ages of 29 and 87 years. Two common patterns of presentations were observed. The most frequent presenting symptom in patients ≤ 60 years (n = 16) was a severe headache (n = 12; 75%) of abrupt onset (n = 9; 56%) with arterial narrowing on conventional angiograms in 4 patients; 10 (p = 0.003) were presumptively diagnosed with a primary vasoconstriction syndrome. Patients > 60 years (n = 13) usually had temporary sensory or motor symptoms (n = 7; 54%); brain MRI scans in these patients showed evidence of leukoaraiosis and/or hemispheric microbleeds and superficial siderosis (n = 9; 69%), compatible with amyloid angiopathy (n = 10; p < 0.0001). In a small group of patients, the presentation was more varied and included lethargy, fever, and confusion. Four patients older than 60 years had recurrent intracerebral hemorrhages in the follow-up period with 2 fatalities.

Conclusion

Convexal subarachnoid hemorrhage is an important subtype of nonaneurysmal subarachnoid bleeding with diverse etiologies, though a reversible vasoconstriction syndrome appears to be a common cause in patients 60 years or younger whereas amyloid angiopathy is frequent in patients over 60. These observations require confirmation in future studies.

---

### Recurrent thunderclap headaches and multilobar intracerebral haemorrhages: two cases of reversible cerebral vasoconstriction syndrome (RCVS) [^6f6fa774]. Cephalalgia (2009). Low credibility.

We describe two patients with thunderclap headaches due to reversible cerebral vasoconstriction syndrome (RCVS). The first patient illustrates multilobar intracerebral haemorrhages as an under-appreciated feature of RCVS, and the second illustrates recurrent thunderclap headache (presumed recurrent RCVS) after a long interval of 4 years. These cases demonstrate the spectrum of presentation of RCVS, a clinically under-recognized condition.

---

### Reversible cerebral vasoconstriction syndrome presenting as subarachnoid hemorrhage: a rare cause of postpartum seizure [^ba908914]. The American Journal of Emergency Medicine (2017). Low credibility.

Reversible cerebral vasoconstriction syndrome (RCVS) is a rare cerebrovascular disorder affecting large- and medium-sized arteries, occurring most commonly in young women. Thunderclap headache is the usual primary symptom; seizure is uncommon. During the postpartum period, seizure is a significant concern. The main causes of postpartum seizures are posterior reversible encephalopathy syndrome and cortical venous thrombosis; RCVS-related postpartum seizure is rare. Despite its rarity, its course may be fulminant, resulting in permanent disability or death if the diagnosis is delayed and treatment is not started promptly. We report an unusual case of RCVS presenting as a subarachnoid hemorrhage in a 31-year-old woman admitted for postpartum seizure.

---

### Clinical reasoning: a 54-year-old woman with progressive headache and neurologic decline [^2a02d89f]. Neurology (2024). Medium credibility.

A 54-year-old woman presented with headache and vasculopathy. She was treated for reversible cerebral vasoconstriction syndrome but continued to have clinicoradiographic decline with headache, seizures, systemic symptoms, and progression of vasculopathy on imaging. We present the diagnosis of a rare genetic disease with its various neurologic complications and systemic manifestations. Our case also illustrates the importance of differences in the metabolism of various antiseizure medications, recognition of which may avoid precipitating the disease.

---

### 2022 AHA / ACC key data elements and definitions for cardiovascular and noncardiovascular complications of COVID-19: a report of the American college of cardiology / American Heart Association task force on clinical data standards [^b5af4b2a]. Journal of the American College of Cardiology (2022). High credibility.

Current symptoms and signs — clinical symptoms: syncope is an abrupt, transient, complete loss of consciousness, associated with inability to maintain postural tone, with rapid and spontaneous recovery, and the presumed mechanism is cerebral hypoperfusion.

---

### Three paediatric patients with reversible cerebral vasoconstriction syndromes [^f8c2e042]. Cephalalgia (2010). Low credibility.

Reversible cerebral vasoconstriction syndromes (RCVS) occur predominantly in middle-aged women. Only one child with RCVS has ever been reported. We report three boys (aged 10, 16 and 10 years) who had multiple thunderclap headaches, including one boy with bath-related attacks. None of them had secondary causes. All their magnetic resonance angiography demonstrated reversible cerebral vasoconstrictions of the major arteries with increased cerebral blood flow velocities on transcranial colour-coded sonography studies. Two of the three had hypertensive surges during headache attacks. None of the three boys had seizure, stroke or other neurological deficits. However, a left occipital subcortical lesion of unknown nature was noted in one boy. The efficacy of calcium channel blockers was variable in these three boys. This report suggests that, although rare, RCVS should be considered in paediatric patients if they present with a history of multiple attacks of thunderclap headache.

---

### Headaches in pregnancy and postpartum: ACOG clinical practice guideline no. 3 [^d72d609a]. Obstetrics and Gynecology (2022). High credibility.

Table 4. Secondary headache types, workup, and treatment — preeclampsia and associated syndromes: For preeclampsia, bilateral occipito-frontal headache with onset at 20 0/7 weeks of gestation or more and BP 140/90 mm Hg or greater with or without visual changes prompts workup with CBC, LFTs, creatinine, UA, urine protein assessment and treatment is Delivery if unresolved. For posterior reversible encephalopathy syndrome (PRES), imaging shows MRI demonstrating white-gray matter edema involving occipital lobes and treatment lists Urgent antihypertensives and Delivery. For reversible cerebral vasoconstriction syndrome (RCVS), vascular imaging shows CTA or MRA demonstrates abnormal cerebral angiography over time and treatment is Delivery.

---

### Reversible cerebral vasoconstriction syndromes presenting with subarachnoid hemorrhage: a case series [^969eb341]. Journal of Neurointerventional Surgery (2011). Low credibility.

Background and Purpose

Reversible cerebral vasoconstriction syndromes (RCVS) represent a heterogeneous group of cerebrovascular disease characterized by acute presentations and transient segmental narrowing of the distal intracranial arteries. A series of patients with RCVS were studied to better understand the clinical and imaging characteristics of this rare pathology.

Methods

A retrospective study was performed on patients that met inclusion criteria for a diagnosis of RCVS. Pertinent clinical and laboratory data, initial and follow-up imaging, treatment and outcomes were studied.

Results

11 patients (10 women, mean age 42 years) diagnosed with RCVS presented with acute onset of severe headache, neurological symptoms and subarachnoid hemorrhage (SAH). Cross sectional imaging (CT/MRI) identified presentations of cortical SAH (n = 9) and/or acute infarcts (n = 3). Initial cerebral angiography (digital subtraction angiography n = 10 or MR angiography n = 1) confirmed diffuse vasoconstriction involving the intracranial vasculature. Rheumatological panel (n = 9) and CSF analysis (n = 8) were not supportive of vasculitis in any patient. In nearly all cases, reversal of vasoconstriction was noted on follow-up cerebral angiography with early resolution in less than 3 months.

Conclusions

RCVS classically presents with 'thunderclap' headaches and neurological symptoms but cortical SAH is not an uncommon presentation with a unique and focal distribution overlying the cerebral sulci. Although the initial clinical and angiographic appearance of RCVS may be confused for vasospasm related to aneurysmal SAH or primary angiitis of the CNS, its clinical, laboratory and imaging features assist in diagnosis.

---

### Grief-induced reversible cerebral vasoconstriction syndrome (RCVS) [^04cf401e]. BMJ Case Reports (2020). High credibility.

Discussion

RCVS is known to affect younger individuals with a female predominance as in the case of our patient. RCVS has a mean incidence around age 42 years, however cases have been described from age 4 months to age 65 years. The most common presentation is multiple recurrent thunderclap headaches over a period of 1 week. The major complication is subsequent cerebral infarction/haemorrhages resulting in permanent residual neurological deficits.RCVS is characterised by prolonged segmental vasoconstriction of anterior and posterior circulation cerebral arteries seen on non-invasive or invasive angiography. RCVS demonstrates a bilateral multiple 'string of beads' appearance of the cerebral arteries caused by segmental vasoconstrictions and post-stenotic dilatations. RCVS is sometimes missed on non-invasive neuroimaging with computed tomography angiogram (CTA)/magnetic resonance angiogram (MRA) and may only be seen using invasive, catheter-based angiography, as in our case. Vasoconstriction can be symptomatic or persist after resolution of symptoms. The vasospasm reversibility must be demonstrated by an angiographic control within 12 weeks after presentation. Reversible cerebral oedema may also be seen in a minority of RCVS patients.

RCVS may occur in pregnancy, post partum, after exposure to drugs with serotonergic and sympathomimetic actions, trauma, HTN, migraine, hypercalcaemia, porphyria or other related conditions. There are no clinical or preclinical studies that clearly delineate the pathophysiology of RCVS, but increased sympathetic drive has consistently been described as a possible inciting factor. Circulating catecholamines are elevated in conditions like pheochromocytoma or after ingestion of sympathomimetic drugs and have resulted in secondary RCVS. In addition, there are multiple reports suggesting that consumption of diet pills and energy drinks containing sympathomimetic compounds have triggered RCVS. The possible inciting ingredients in these reports include green tea, L-carnitine, conjugated linoleic acid, the weight-loss supplement Hydroxycut, Chinese medicine containing ephedra and 'energy drink' containing numerous sympathomimetic herbal compounds.

---

### Clinical significance of centripetal propagation of vasoconstriction in patients with reversible cerebral vasoconstriction syndrome: a retrospective case-control study [^0e950769]. Cephalalgia (2018). Low credibility.

Clinical features of the chronic stage

As seen on MRA, multifocal vasoconstriction, which disappeared within 12 weeks, was confirmed in all 48 RCVS patients. No patients with progression of periventricular WMH were seen in either RCVS patient group. In RCVS patients with CPV at the time of TCH remission, the frequency of the progression of DSWMH (42%: 10 of 24 cases) was higher than in RCVS patients without CPV at the time of TCH remission (33%: 8 of 24 cases), but the difference was not statistically significant. DSWMH of 3 mm or more appeared only in five out of 48 patients (10%), four of whom were RCVS patients with CPV, but no significant difference was present. Three months later, the modified Rankin scale score was 0 in all 48 of these RCVS patients, and they were all able to resume their prior daily activities.

Multivariate analysis was not performed due to the small number of RCVS patients with CPV at the time of TCH remission (n = 24).

---

### Reversible cerebral vasoconstriction syndrome with concurrent bilateral carotid artery dissection [^3e3a7bbe]. Cephalalgia (2013). Low credibility.

Background

The pathophysiological basis of reversible cerebral vasoconstriction syndrome is poorly understood but carotid artery dissection has been discussed as a rare possible cause. So far, only single cases of unilateral carotid artery dissection and reversible cerebral vasoconstriction syndrome have been reported.

Case

Here, we describe the case of a 54-year old patient presenting to the emergency department with right hemiparesis, hypaesthesia and dysarthria. Furthermore, he reported two episodes of thunderclap headache after autosexual activity. Cerebral imaging showed ischaemic infarcts, slight cortical subarachnoid haemorrhage, bilateral carotid artery dissection and fluctuating intracranial vessel irregularities, compatible with reversible cerebral vasoconstriction syndrome. An extensive diagnostic work-up was normal. No typical trigger factors of reversible cerebral vasoconstriction syndrome could be found. The patient received intravenous heparin and the calcium channel blocker nimodipine. Follow-up imaging revealed no vessel irregularities, the left internal carotid artery was still occluded.

Conclusion

This case supports the assumption that carotid artery dissection should be considered as a potential trigger of reversible cerebral vasoconstriction syndrome, possibly by altering sympathetic vascular tone.

---